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 Creation of the next generation by sexual reproduction requires the fusion of male 
and female gametes.  For many species, this entails a sessile oocyte and a highly motile 
spermatozoon with remarkable ability to sense and migrate through the often structurally 
and chemically complex reproductive tract of a female.  Despite many years of research, 
our understanding of the basic components of male-factor infertility, in any species, is 
poor.  While we know of many factors involved or associated with sperm success, few 
have been well characterized at the molecular level.  Understanding how sperm 
successfully accomplish their journey is critical to human health and the health of 
ecosystems that hinge on the reproductive success and balance of species within.   
 The study of reproductive biology is challenging partially due to the lack of direct 
conservation in many genes involved in the process of reproduction.  Therefore, it is 
critical to investigate reproduction in a wide variety of species both to identify conserved 
themes and also to discover novel cell biological processes.   
 In this dissertation, I study the secreted serine protease inhibitor SWM-1, a 
protein known for its critical role in male fertility of the nematode Caenorhabditis 
elegans.  Through this work, I have discovered that SWM-1 is produced in an unlikely 
source of somatic cells: body wall muscle.  From muscle, SWM-1 is secreted into the 
body fluid of the worm and enters the gonad to perform its critical role of preventing 
sperm from premature motility, which causes male infertility.  I show that there is bi-
iv 
directional movement of proteins between the body fluid and gonadal structures, which 
may be a widespread phenomenon.  Through this work, I also discovered that SWM-1 is 
a seminal fluid protein and a component of the sperm migratory environment though its 
role in this environment remains unknown.  I expand on our knowledge of the molecular 
relationship to SWM-1’s likely target, the protease TRY-5, by probing its protease 
inhibitory domains and visualizing SWM-1 and TRY-5 in combination.  Lastly, I began 
initial characterization of other mutants that affect the acquisition of motility. 
This work adds to the knowledge of the role of proteolysis regulators in male 
reproductive success and the regulation of cell motility.  Moreover, my finding that 
muscle is a source of SWM-1 and that SWM-1 is also a seminal fluid protein reveals a 
novel means of ensuring sperm success and highlights the utility of C. elegans as a 
system to study secretory and reproductive biology.  
Protease signaling regulates sperm activation in C. elegans 
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Sexual reproduction requires the generation of highly differentiated sperm cells 
with specialized structures and cellular characteristics that support navigation to and 
fusion with an oocyte.  However, immediately following meiosis, sperm can neither 
migrate, nor fuse with an oocyte.  To gain fertilizing ability, sperm morphology and 
physiology transform significantly to permit movement, navigation, and fusion.  This 
transformation is regulated exclusively by cues that originate from the male and female 
reproductive tracts, as the tightly compacted genome of the sperm cell does not 
synthesize new protein products to aid in the demands of its journey (Figure 1.1) 
(reviewed in Gervasi and Jin and Yang, 2017 and Visconti, 2017).   
Studies on postmeiotic sperm development have been carried out in a variety of 
model and nonmodel organisms as well as in humans, revealing interesting differences 
and similarities between species.  One significant difference is at the genetic level: genes 
that regulate sperm maturation are some of the most rapidly evolving genes in the 
genome (Swanson and Vacquier, 2002).  Sperm morphology is also highly variable 
between species (Alvarez, 2017).  Despite these genetic and morphological differences, 
the classes of proteins involved in reproduction are conserved in many taxa and 
morphologically diverse sperm undergo analogous maturation processes, many of which 
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are carried out by conserved cellular machinery (Figure 1.1) (Fraire-Zamora and Cardullo 
2010; Mueller et al., 2004).  Thus, a better understanding of sperm maturation from the 
perspective of a wide variety of species will aid in our knowledge of both conserved and 
novel reproductive and cell biology.   
The study of sperm development in a wide range of species has also uncovered 
interesting secretory biology and highly regulated production of sperm maturation cues 
by many cell types along the length of winding, tube-shaped reproductive tracts.  Overall, 
this process is poorly understood but provides an opportunity to understand how an 
organism can create a complex signaling environment using inputs from many different 
cell types.  Furthermore, although many mammalian reproductive systems are studied 
extensively, including mouse, bull, boar, and stallion, many suffer from a lack of testable 
in vivo or ex vivo models.  Thus, investigation of sperm maturation in a variety of species 
is important for understanding male-factor infertility, mechanisms of cell migration, cell 
secretion, and evolution through sexual selection. 
This is a dissertation on the regulation of postmeiotic sperm maturation in the 
nematode Caenorhabditis elegans.  In this male/hermaphrodite species, the sperm 
maturation process is known as sperm activation and is regulated by proteolysis 
regulators present in the male and hermaphrodite reproductive tracts.  The worm has 
proven to be an excellent model system to study various of aspects of reproductive 
biology including the germline stem cell niche, molecular mechanisms of meiosis, oocyte 
development and postmeiotic sperm maturation (Figure 1.1, Figure 1.2) (Corsi et al., 
2015).  In this introduction, I briefly describe important aspects of postmeiotic sperm 
maturation in the male and female reproductive tracts, drawing from our knowledge in 
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various mammals, insects and C. elegans, while highlighting the role of proteolysis 
regulators that are important for sperm function and cell motility. 
 
Sperm maturation in the male reproductive tract 
After meiosis, sperm produced in the testis enter the somatic gonad, tube-shaped 
tissues through which they pass and begin the maturation process prior to being 
transferred to a female.  In mammals, these tissues include the epididymis and the vas 
deferens.  Insects and C. elegans have simplified male reproductive tracts but many 
parallels can be made, as they are also tube-shaped structures that secrete complex 
repertoires of proteins from a variety of different cell types ( L'Hernault, 2017; McGraw 
et al., 2015; Nishimura).  In mammals, the male reproductive tract causes changes to 
sperm cell physiology that prime the cell for its journey in the female.  These regulated 
changes include significant alterations to the molecular composition and morphology of 
the sperm membrane and intracellular physiology that allows sperm to progressively gain 
motility (Figure 1.3) (Dacheux et al., 2003).  Our current understanding of the sperm 
maturation processes that takes place in the male reproductive largely relies on 
comparisons between sperm and somatic gonad tissue analyzed prior to, during, and after 
transit through the epididymis and vas deferens as well as immunohistochemical analysis 
and gene expression profiling of different parts of the reproductive tract (Belleannée et 
al., 2012; Chalmel and Rolland, 2015; Zhang et al., 2006).  While these studies have 
identified many factors that are important for sperm development, few of these factors 
have been experimentally verified.  Thus, understanding the molecular mechanisms that 
will be helpful for developing fertility or contraceptive treatments will benefit from the 
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development of in vitro and ex vivo models, and model organism studies, as many 
maturation factors have conserved molecular structure and function (Druart et al., 2013; 
McGraw et al., 2015).   
 
Changes in sperm membrane composition 
During epididymal maturation, the membrane composition of sperm is 
significantly altered to prepare the sperm to survive in the female.  As one mechanism for 
this, the sperm membrane can be altered by the incorporation of proteolysis regulators 
that have important functions in the later part of the journey in the female.  For example, 
the serine protease inhibitor Spink-3 (serine protease inhibitor kazal-type 3), is produced 
in the seminal vesicles of mice and incorporated into the sperm membrane during transit 
through the epididymis (Lai et al., 1991; Ou et al., 2012).  This protease inhibitor is 
transferred with sperm to females during mating and is progressively removed from the 
membrane during migration through the female; whereas as uterine sperm have Spink-3 
in their membranes, sperm that have migrated to the oviduct lack Spink-3 (Ou et al., 
2012).  Although the exact function(s) of Spink-3 are not precisely defined, it is proposed 
to inhibit female-derived proteases and prevent premature acrosome reaction until the 
sperm cell reaches the oocyte (Ou et al., 2012; Zalazar et al., 2012).   
Another important change that occurs is alterations of the sperm gylcocalyx, the 
coat of sugar molecules in the sperm membrane.  As sperm enter the epididymis, the 
surface of their membrane becomes decorated with various sugar molecules acquired 
from different parts of the epididymis.  In humans, some glycoproteins that sperm acquire 
during transit through the epididymis include GPI-anchored proteins that are important 
  
5 
for immune protection, and beta defensin, which is important for navigating the female 
reproductive tract (Kirchhoff and Hale, 1996; Tecle and Gagneux, 2015).  These proteins 
are secreted from the epithelium of the epididymis and can be incorporated into the sperm 
membrane.  Furthermore, humans express lectins, a class of carbohydrate-binding 
proteins along the length of the epididymis, which are expressed in region-specific 
patterns, suggesting that regulation of sugars on the surface of the sperm membrane is 
important (Arenas et al., 1996).  The lipid content of the sperm membrane is also altered 
during epididymal transit.  Analysis of sperm prior to and following epididymal 
maturation has shown that the cholesterol content is decreased in more mature sperm 
(Gervasi and Visconti, 2017). 
 Not only can the sperm membrane be altered by secretions in the lumen of the 
epididymis, sperm can acquire proteins and gain membrane from exosomes secreted by 
the reproductive tract known as epididymosomes (Cooper, 1998; Martin-DeLeon, 2015).  
Roles for epididymosomes have been implicated in preparing the sperm membrane for 
survival, motility, and fusion (Girouard et al., 2011; Sullivan et al., 2005; Sullivan et al., 
2007).  Epididymosomes carry a wide variety of cargo that differs depending on the 
location along the epididymis from which they are isolated.  For example, proteomic 
analysis of epididymosomes purified from bovine vas deferens showed that its cargo 
includes proteases and protease inhibitors (Girouard et al., 2011).  These types of studies 
are challenging to perform in humans yet one study has analyzed the proteome of human 
epididymosomes of men undergoing vasectomy reversal.  This study revealed that 
purified epididymosomes contain proteolysis regulators, some of which previously have 
been shown to have important sperm maturation roles (Thimon et al., 2008).  Recent 
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work has provided evidence that epididymosomes can also deliver RNA molecules, 
which has been proposed to have implications in modifying DNA methylation (Reilly et 
al., 2016).   
Exosomes have also been reported in the male reproductive tract of Drosophila.  
In this study, researchers showed dynamic fusion events of exosomes in vivo, an 
important step in understanding the role and molecular mechanisms by which 
epididymosomes may fuse with sperm (Corrigan et al., 2014).  In C. elegans, such 
vesicles secreted by the male have not been reported.  However, larger seminal fluid-
containing vesicles are present in the C. elegans vas deferens.  Furthermore, membrane 
from these vesicles is transferred to hermaphrodites during mating (Angela Snow and 
Gillian Stanfield, University of Utah, personal communication).  Although the presence 
of epididymosomes in C. elegans is unproven, this system would provide an excellent 
opportunity to investigate membrane dynamics as the worm is transparent.  Overall, it is 
well accepted that epididymosomes play a role in sperm maturation in many systems, but 
much more investigation is needed to determine the mechanism of cargo transfer.   
 In flagellated sperm, the most obvious change to sperm cell morphology during 
maturation in the male includes migration of the cytoplasmic droplet (CD).  During 
meiosis, sperm release a residual body of cytoplasm with the exception of the CD, which 
moves posteriorly after transit through the epididymis.  The role of the CD is not clear 
although it likely provides many maturation factors and regulates several processes as a 
variety of molecules have been identified in purified CDs.  For example, the 
metalloprotease ADAM3 is required for sperm to enter the female, a process that is 
dependent on the CD protein Tex10 (Gervasi and Visconti, 2017; Yamaguchi et al., 
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2009).   
 
Sperm maturation in the female reproductive tract:  
seminal fluid and female response 
 
 Once sperm leave the male and enter the female, they encounter a tremendously 
complex environment.  In the female, sperm face the challenge of adapting to pH, 
hyperactivating flagellar beating, avoiding the female immune response, navigating to the 
oocyte, and competing with other sperm.  Lastly, sperm must undergo the acrosome 
reaction, a specialized exocytic event that allows fusion with the egg.  Combating these 
challenges requires inputs from the female and also from males in the form of seminal 
fluid.  Collectively, the sperm maturation processes that take place in the female, which 
results in a fertilization-competent cell, is known as capacitation.   
 
 
Seminal fluid composition and function 
 The majority of semen is made up of nonsperm components.  Seminal fluid 
includes proteins, carbohydrates, lipids, and some immune cells (Poiani, 2006).  The 
molecules in seminal fluid have critical and diverse functions in fertility including: 
facilitating and regulating sperm migration, navigation, completion of the acrosome 
reaction, and penetration of the oocyte oolemma.  However, for the large majority of 
seminal fluid factors, functions have not been determined (Robertson and Sharkey, 2016; 
Wolfner, 2007).  Various studies have sought to identify the components of seminal fluid 
in humans, agriculturally important bovines, and various insects (Druart et al., 2013; 
Jodar et al., 2017; Mueller et al., 2004; Pilch and Mann, 2006; Robertson, 2007).  These 
studies have revealed that there are a large number of proteins in seminal fluid.  For 
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example, there are ~900 in humans and ~200 in Drosophila (Laflamme and Wolfner, 
2013).  While most of the seminal fluid proteins that have been identified are not 
conserved between species, the major classes of proteins represented are conserved 
among evolutionarily distant taxa (Druart et al., 2013).   
 Classes of conserved proteins include proteases and protease inhibitors, mucins, 
carbohydrate-binding lectins and insulins (Pilch and Mann, 2006; Poiani, 2006).  In 
humans, proteolysis regulators compose ~10% of the proteins in seminal fluid (Laflamme 
and Wolfner, 2013).  One well-known role for seminal fluid proteins is to aid in the 
regulation of sperm migration.  In mammals, sperm progressively begin moving their 
flagella during transit in the epididymis.  However, in the female, seminal fluid forms a 
coagulum primarily formed of semenogelin proteins, which forms a clot that restricts 
sperm movement (Jonsson et al., 2005).  Within minutes, a chymotrypsin-like protease, 
prostate-specific antigen (PSA) degrades semelogelins, freeing sperm to continue to the 
oocyte (de Lamirande, 2007).  Another mammalian proteolysis regulator important in the 
capacitation process is the serine protease inhibitor, Kasal-type-like protein (SPINKL).  
SPINKL is expressed exclusively in the seminal fluid-producing seminal vesicles and 
transferred to the female during mating.  In vitro, SPINKL inhibits capacitation but its 
role in vivo has not been determined (Lin et al., 2008). 
Perhaps the most thoroughly investigated organisms in terms of seminal fluid 
composition, production, and function, is Drosophila.  In the fly, there is a cascade of 
proteolytic events that begins in the male with cleavage of the trypsin-like protease, 
called seminase (Laflamme et al., 2012).  This proteolytic cleavage is important for the 
binding of a peptide hormone, sex peptide, to sperm, which in turn is responsible for a 
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collection of events known as the female mating response.  The female mating response 
includes increased egg laying and release of stored sperm (Chapman et al., 2003).  As in 
mammals, Drosophila male reproductive tract tissues secrete two carbohydrate binding 
lectins.  These lectins are produced in the male accessory glands and are components of 
seminal fluid required for the female mating response (Sitnik et al., 2016).  Indeed, the 
fly has been a critical model for studying reproduction due to its anatomically analogous 
tissues and conserved molecular machinery (Wolfner, 2002). 
 Some seminal fluid proteins cause significant morphological changes required for 
regulation of motility, especially in the case of aflagellate sperm.  Some species that 
produce aflagellate sperm include nematodes (round worms), Annelids (segmented 
worms), and some species of Arachnids (spiders) (Morrow, 2004).  The most well studied 
aflagellate sperm are those of the nematodes, C. elegans and Ascaris, which undergo a 
dramatic transformation called sperm activation in response to proteolysis regulators 
derived from the male reproductive tract (Figure 1.2).  During sperm activation, the cell 
membrane is rearranged and becomes polarized with a cell body that contains the nucleus 
at one end and a pseudopod, which is used to crawl, at the opposite end of the cell (Figure 
1.2) (Bottino et al., 2002; Shakes and ward, 1989; Ward et al., 1983).  This process is 
triggered by the trypsin-like protease, TRY-5, a serine protease that is a component of 
seminal fluid.  Sperm activation via TRY-5 activity is restricted in the male by a protease 
inhibitor, SWM-1, expressed in both males and hermaphrodites (Chapter 2).  Once TRY-
5 is transferred to hermaphrodites in seminal fluid, sperm become activated in the uterus 
and begin crawling towards oocytes (Smith and Stanfield, 2011; Stanfield and 
Villeneuve, 2006). Interestingly, SWM-1 is also a seminal fluid protein, and it is 
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transferred to hermaphrodites along with TRY-5 (Chapter 2).  While SWM-1 in the 
hermaphrodite can affect male fertility, how and why it affects sperm in the uterus 
remains elusive (Chapter 2 and Appendix).  While there is evidence that SWM-1 directly 
inhibits TRY-5, the exact molecular mechanism by which they act to regulate activation 
has yet to be determined.   
 Another known seminal fluid protein in C. elegans is the mucin PLG-1 (Hodgkin 
and Doniach, 1997; Palopoli et al., 2008).  PLG-1 forms a mating plug in the 
hermaphrodite vulva following copulation to prevent mating by other males.  Aside from 
PLG-1, TRY-5 and SWM-1, no other seminal fluid proteins have been confirmed in C. 
elegans.  However, there are a number of putative seminal fluid proteins that are 
expressed in the male vas deferens and represent the classes of seminal fluid proteins 
commonly found in most species.  These include an insulin, another mucin, and a lectin 
(Angela Snow, Gillian Stanfield, University of Utah, personal communication; Thoemke 
et al., 2005).  Although few seminal fluid proteins are well-characterized in C. elegans, 
collectively, seminal fluid has been shown to have a dramatic effect on the health of the 
hermaphrodite after mating, causing shortened life span in an insulin signaling-dependent 
manner (Shi and Murphy, 2014).   
 
Changes to the sperm membrane in the female 
The central event of fertilization is the fusion of the two gamete membranes.  
Thus, the sperm cell is designed to precisely sense its target and prepare for fusion.  The 
molecular means by which sperm prepare for this fusion is challenging to study in vivo, 
and most studies have been performed in vitro, though in vivo mouse models are 
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increasingly being utilized.  While these mechanisms are not well understood, it is well 
accepted that changes in membrane fluidity via reduction of cholesterol and controlled 
production of reactive oxygen species is important (reviewed in De Jonge, 2017; de 
Lamirande et al., 1997; Stival et al., 2016; ).  Furthermore, until sperm are in close 
proximity to the egg, the flagellar beating is not sufficient to penetrate the egg oolema.  
Rather, sperm must initiate what is called hyperactivation of flagella, an asymmetrical, 
rapid flagellar beating motion which is regulated by an influx of calcium through cation 
channel sperm-associated (CatSper) channels (Suarez, 2008). 
In the reproductive tract of mammalian females, the most significant membrane 
rearrangement is the acrosome reaction.  The acrosome is a specialized sperm organelle 
located in the sperm head which fuses with the sperm membrane during a highly-
regulated exocytic event (Ickowicz et al., 2012).  Only an acrosome-reacted sperm cell 
can penetrate the oocyte and complete successful fertilization.  Furthermore, spatial and 
temporal regulation of the acrosome reaction is critical as fertilization requires that it 
occur only when sperm is in close proximity to the oocyte in the oviduct (De Jonge, 
2017).  C. elegans sperm also perform specialized membrane fusion events required for 
fertilization.  In C. elegans, sperm contain multiple golgi-derived membranous organelles 
(MOs) that fuse with the plasma membrane, which is analogous to the acrosome reaction 
and prerequisite for fertilization.  MOs are highly regulated to release major sperm 
protein, which acts as both a motility-driving protein in the pseudopod and also a 





Protease signaling in the regulation of cell motility 
Aside from sperm, many other cell types are required to migrate, for example, as 
a mechanism of wound healing and also during developmental processes such as 
gastrulation (Heutinck et al., 2010; Rau et al., 2007) (Keller, 2005).  Regulation of cell 
migration via proteolysis is an efficient means to create a rapid, posttranslational 
response such as those needed during immune response to injury and the acquisition of 
sperm motility.  On the other hand, misregulation of cell migration can lead to various 
disease states including cancer metastasis, which involves proteolytic degradation of the 
extracellular matrix (Stetler-Stevenson et al., 1993).  Other cell motility-regulating 
mechanisms are required intracellularly.  Such is the case for SERPINB1, an intracellular 
protease inhibitor that regulates proteolysis in response to cellular stress.  When 
misregulated, SERPINB1 has been associated with oral cancers and with increased cell 
migration upon overexpression (Torriglia et al., 2017). 
 
Dissertation summary 
The cellular mechanisms by which sperm success is ensured are undoubtedly 
complex and challenging to study.  Considering the intricacy of the tissues that generate 
sperm maturation cues, and the extensive cell signaling involved, it is not surprising that 
our current understanding of male-factor infertility, in any organism, is far from 
complete.  Yet given our rapidly changing environment, increasing age of paternity, and 
recently compiled large-scale data showing a severe decline in human sperm 
concentration, it is important to gain a basic understanding of what makes sperm 
successful.  Since reproductive-related genes are rapidly evolving, it is critical to carry 
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out studies in a wide variety of organisms (Levine, 2017).   
 In this dissertation, I study the role of the protease inhibitor SWM-1 in the 
regulation of C. elegans sperm activation.  In Chapter 2, I use precise genetic 
manipulation and microscopy to analyze the expression and protein localization of SWM-
1.  Using tissue-specific expression of SWM-1, I find that it is produced in, and secreted 
from, extra-gonadal muscle cells into the body cavity of the animal, where it is present in 
the body fluid from which it can enter the gonad and inhibit premature activation by the 
protease TRY-5.  I expand these studies to test models of inhibition of TRY-5 and also 
explore the extent to which other molecules are exchanged between body fluid and the 
gonad.   
 In Chapter 3, I describe my work testing the role of the SWM-1 protease inhibitor 
domains.  These results provide additional evidence supporting previous results, which 
suggested that SWM-1 may have multiple protease targets.  In Chapter 4, I describe 
preliminary analysis of the results of a swm-1 suppressor screen that sought to identify 
additional genes involved in the regulation of sperm activation.  Lastly, the Appendix 
contains a preliminary analysis of the role of swm-1 in sperm competition.  I conclude 
with a brief summary of my findings, extended interpretations of results, considerations 
for future work on these projects, and I share my ideas on how to test the many new 
questions that have arisen from my findings.   
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Figure 1.1 C. elegans sperm use conserved cellular machinery. Schematic of 
postmeiotic sperm maturation in mammals and C. elegans. The product of mammalian 
and C. elegans male meiosis is an immature sperm cell that is not competent to fertilize 
an oocyte.  Both sperm are transcriptionally quiescent and rely on extracellular 
maturation cues to undergo directed migration and specialized membrane changes 
including exocytic events to be fertilization competent.  List includes C. elegans genes 
that are involved in the indicated process which are analogous or conserved between 































































































































































































































































































































































Figure 1.2 Spatial and temporal regulation of C. elegans sperm activation. Sperm are 
produced in the male reproductive tract as round, immotile spermatids and maintained in 
the nonactivated state until transfer to the hermaphrodite.  In the hermaphrodite, sperm 
become polarized and extend a pseudopod used to crawl towards oocytes.  Activation is 



































Figure 1.3 The extracellular environment regulates sperm motility.   Schematic of 
maturation processes important for fertility.  Changes to the sperm occur in response to 
signals secreted by the male and female reproductive tracts.  The sperm membrane 
composition is altered in males and females to prepare sperm for fusion with the egg in 
response to female signals and male signals transferred in seminal fluid.  Full flagellar 






THE MUSCLE-DERIVED PROTEASE INHIBITOR, SWM-1, REGULATES C. 
ELEGANS SPERM MOTILITY 
 
Abstract 
The development of highly differentiated sperm cells that specialize in navigating 
to and fusing with an oocyte is critical for sexual reproduction.  As a major part of their 
differentiation, sperm undergo postmeiotic maturation en route to the oocyte.  In C. 
elegans, this maturation process is called sperm activation, and it transforms immotile 
spermatids into migratory, fertilization-competent cells.  Here we use precise genetic 
engineering to study the protease inhibitor SWM-1, the negative regulator of C. elegans 
sperm activation, to understand how males generate a signaling environment that 
precisely regulates activation at the level of the whole organism.  We show that SWM-1 
is produced in an unexpected source of extragonadal cells: body wall muscle.  From 
muscle, SWM-1 is secreted into the body cavity and enters the gonad; there it is in close 
proximity with its likely target, TRY-5, a secreted serine protease that triggers activation.  
We extend these studies to show that the somatic gonad and body fluid can exchange 
other factors, which may be a means of soma-germline communication for other 
reproductive processes.  Through genetic analysis, we determine that SWM-1 and TRY-5 
can localize to the gonad independently of one another, expanding on our understanding 
of how these protease signals regulate the acquisition of motility.  Lastly, we show that 
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SWM-1 is a component of the sperm migratory environment and is contributed by males 
in seminal fluid and also by hermaphrodites. 
 
Introduction 
Sexual reproduction requires the development and differentiation of sperm cells 
capable of migrating to and fusing with an oocyte.  To become fertilization competent, 
sperm undergo significant postmeiotic morphological and physiological changes, all of 
which occur in the absence of synthesizing new protein products.  This maturation occurs 
in response to extracellular cues generated by specialized support cells of the male and 
female reproductive tracts.  In mammals, sperm progressively mature within the male as 
they pass along the considerable length of the male gonad.  Within the labyrinthine 
epididymis and the vas deferens, different cell types secrete distinct repertoires of factors 
including proteins, sugars, lipids, and vesicles (Belleannée et al., 2012; Zhang et al., 
2006).  These cues cause changes to sperm membrane fluidity and cell morphology, and 
also trigger biochemical modifications required for fertilization (reviewed in Gervasi and 
Visconti, 2017).  Within the female, additional male and female factors complete the 
maturation process required for maximum forward movement and induction of the 
acrosome reaction, resulting in the highly specialized cell that locates and fuses with the 
oocyte (reviewed in Abou-haila and Tulsiani, 2009; de Lamirande et al., 1997; and 
Salicioni et al., 2007).   
In all species that have been investigated, a significant proportion of factors that 
regulate postmeiotic sperm development are secreted proteolysis regulators (Jodar et al., 
2017; Laflamme and Wolfner, 2013).  For example, in mice, proteolysis-regulated 
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processes include increased flagellar beating by degradation of proteins that inhibit 
motility, as well as proper localization of the sperm cell in the female reproductive tract 
(Christensson et al., 1990; Jonsson et al., 2005; Martin Robert et al., 1997; Yamaguchi et 
al., 2009) .  In Drosophila, the seminal fluid protease inhibitor Acp62F is important for 
ovulation and is also involved in sperm competition (Mueller et al., 2008).   
The nematode Caenorhabditis elegans represents a simple model to study how 
protease signaling regulates sperm maturation and post-translational cell motility.  In C. 
elegans, both males and hermaphrodites produce amoeboid sperm (Ward and Carrel, 
1979; Ward, 1977).  Meiotic cell division results in haploid spermatids that are initially 
immotile.  Upon receiving a signal, spermatids become polarized and generate 
pseudopods, which they use to migrate towards oocytes (Bottino et al., 2002; Ward and 
Carrel, 1979).  This differentiation process is called sperm activation, and it is thought to 
result in spermatozoa that are fully competent for fertilization.  Spermatids are stored in 
their nonactivated form within a region called the seminal vesicle.  During mating, cells 
along the length of a tube-shaped vas deferens release seminal fluid components at 
specific times and locations, and these are transferred along with spermatids to the 
hermaphrodite uterus.  Rapid activation into functional spermatozoa ensues. 
Two critical regulators of sperm activation are the protease TRY-5 and the trypsin 
inhibitor-like (TIL) protein SWM-1 (Smith and Stanfield, 2011; Stanfield and 
Villeneuve, 2006).  TRY-5 is thought to be the sperm activation-promoting signal in 
seminal fluid.  Conversely, SWM-1 inhibits activation; swm-1 mutant males contain 
prematurely activated sperm and are frequently infertile due to the inefficient transfer of 
sperm (Stanfield and Villeneuve, 2006).  TRY-5 is required for this premature activation, 
  
26 
and it is visible at elevated levels near activated sperm in swm-1 mutants.  Thus, by their 
opposing activities, SWM-1 and TRY-5 ensure male fertility by signaling sperm 
differentiation to occur only at the right place and time.  Yet how SWM-1 inhibits TRY-5 
from prematurely activating sperm in the male has been unknown, both in terms of where 
SWM-1 originates and its relationship to TRY-5 localization and/or activity. 
Here, we describe how this critical developmental transition is regulated at the 
whole-organism level.  Using CRISPR-mediated genome engineering and analysis of 
protein localization in mutants defective for regulators of sperm activation, we determine 
where SWM-1 localizes and functions in conjunction with TRY-5.  We show that, 
surprisingly, the SWM-1 inhibitor is produced in and secreted from extra-gonadal muscle 
cells into the body cavity (pseudocoelom) that surrounds the gonad.  SWM-1 then enters 
the seminal vesicle, where it is coincident with TRY-5 protein localization.  Furthermore, 
SWM-1 produced in the gonad is released into the body cavity, and this bidirectional 
exchange of proteins between the body cavity and the somatic gonad may be a general 
phenomenon.  Lastly, we find that SWM-1 is contributed by males in seminal fluid, and 
also by hermaphrodites to the sperm migratory environment, the hermaphrodite uterus, 




swm-1 is expressed in the male somatic gonad  
and in extra-gonadal muscle cells 
 
We sought to determine where SWM-1 is expressed in males.  To identify cells 
that produce SWM-1, we generated strains carrying a transcriptional reporter, Pswm-
1::mCherry::H2B, in which the swm-1 promoter region controls expression of an 
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mCherry-tagged histone protein (Merritt et al., 2008).  Based on its amino acid sequence, 
SWM-1 is predicted to be a secreted protein; this strategy allowed us to identify cells that 
express swm-1 based on the position of mCherry-positive nuclei.  We used Mos-mediated 
Single-Copy Insertion (MosSCI) to insert the desired sequences at the ttTi5605 locus 
(Materials and methods and supplemental data) (Jensen et al., 2008).  Importantly, 
control strains with this promoter driving expression of full-length SWM-1 showed 
strong rescue of the swm-1(me87) null mutation (Supplemental data).   
We found that swm-1 is transcribed in both gonadal and extragonadal somatic 
tissues (Figure 2.1).  In C. elegans males, the gonad forms a tube structure with germline 
stem cells at the distal end that proliferate and move proximally to undergo meiotic 
divisions and give rise to spermatids.  At the L4 larval stage of development, spermatids 
begin to be produced and are stored in the seminal vesicle (Kimble and Hirsh, 1979).  
The vas deferens is at the proximal end of the gonad and forms a complex secretory tube 
through which sperm pass during mating.  The vas deferens contains at least three cell 
types: valve cells, cuboidal cells, and elongated cells (Lints and Hall, 2009), two of which 
have been shown to produce seminal fluid (Smith and Stanfield, 2011).  By 24 hours 
post-L4, adult males have a fully-developed gonad and sperm have accumulated in the 
seminal vesicle.   
We observed Pswm-1::mCherry::H2B reporter expression in 6-8 of the twelve 
vas deferens cuboidal cells (Figure 2.1A,B).  We also observed Pswm-1::mCherry::H2B 
in posterior body wall muscle cells and in the male-specific diagonal muscle cells, both 
of which overlie the seminal vesicle and vas deferens region (Figure 2.1C-F) (Sulston et 
al., 1980).  We confirmed the identity of these cells by co-localization with a 
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Pmyo::GFP::H2B reporter transgene, which drives expression of nuclear-localized GFP 
in body wall and diagonal muscles (Figure 2.1E,F) (Fire et al., 1990).  Expression of the 
Pswm-1 reporter in both gonadal and muscle cells began at late larval stages and persisted 
until at least 48 hr post L4 (supplemental data).  Additionally, we observed reporter 
expression at low levels in two cells in the head, which likely were neurons 
(supplemental data).  These data indicate that swm-1 is not expressed in sperm.  Instead, 
it is produced in somatic tissues, including the vas deferens, which is involved in the 
production and release/transfer of seminal fluid, as well as in tissues outside the gonad, 
muscle cells.  These data suggest that somatic tissues are important for the regulation of a 
crucial step of sperm development, the acquisition of motility.   
 
 
SWM-1 is secreted into the body cavity and  
surrounds sperm in the seminal vesicle 
 
To determine where SWM-1 protein localizes, we generated worms expressing a 
SWM-1::mCherry fusion protein.  Using a knock-in CRISPR strategy adapted from 
Arribere (2014) and Ward (2015), we inserted mCherry coding sequences at the 
endogenous swm-1 locus.  Briefly, we targeted Cas9 to two sites, one in swm-1 and one 
in the neighboring gene C25E10.8, while providing a repair template to introduce 
mCherry (Materials and Methods, supplementary data).  We isolated two independent 
lines: swm-1(jn60) and swm-1(jn62).  To determine if these strains had the desired 
alterations, we sequenced the swm-1 gene and repair template region in both lines.  The 
jn62 allele had repaired as designed in the template.  However, the jn60 allele contained 
an alteration of amino acids 24 and 25 from two glutamate residues (EE) to valine and 
lysine (VK), as well as a silent mutation in codon 22.  To test if these SWM-1::mCherry 
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fusion proteins were functional, we quantified sperm activation in jn62(swm-1::mCherry) 
and jn60(swm-1(EEtoVK)::mCherry) males (Figure 2.2A).  jn62[swm-1::mCherry] male 
sperm appeared essentially wild-type, although we observed slightly elevated levels of 
sperm activation in older adults.  Thus, SWM-1::mCherry was functional and capable of 
inhibiting activation in vivo.  However, the jn60(swm-1(EEtoVK)::mCherry) line showed 
increased levels of activation in both 24 hr and 48 hr adults as compared to either the 
jn62 line or wild-type males (Figure 2.2A), indicating that the introduced mutations 
impaired swm-1 function.  Thus, we primarily used the jn62 line to analyze SWM-1 
localization, largely focusing on localization in adult males, when regulation of activation 
is most critical.  However, we also examined protein localization throughout 
development (supplementary data). 
In adult males, the SWM-1::mCherry protein localized to cells where we observed 
the transcriptional reporter: 6-8 of the twelve vas deferens cuboidal cells, diagonal 
muscles, and body wall muscles (Figure 2.2B-E).  However, in the knock-in worms, 
SWM-1::mCherry was visible in most or all body wall muscles, rather than being 
restricted to the posterior region.  Within cuboidal cells, SWM-1::mCherry was contained 
within large vesicles closely associated with the apical membrane (Figure 2.2D,E and 
supplementary data), which are not well-characterized, but have been shown to contain 
seminal fluid (Smith and Stanfield, 2011) (Lints and Hall, 2009) (Kimble and Hirsh, 
1979).  In muscle cells, we observed SWM-1::mCherry at low levels that showed no 
obvious pattern of subcellular localization (Figure 2.2C).  Interestingly, in jn62 males, 
SWM-1(EEtoVK)::mCherry was visible in muscle at higher levels and at an earlier 
developmental stage as compared to the wild-type fusion protein (supplementary data), 
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suggesting that its secretion might be impaired.  The SWM-1::mCherry protein also 
localized to tissues where we did not detect swm-1 expression.  It was present throughout 
the body cavity (pseudocoelom) and in coelomocytes (Figure 2.2H,I), which are large 
mesodermal cells that reside within the body cavity and take up soluble material (Fares 
and Greenwald, 2001; Zhang et al., 2001).  Most notably, SWM-1::mCherry was present 
in the seminal vesicle, as well as the valve region in young adults (Figure 2.2F,G and 
supplementary data).   
SWM-1::mCherry surrounded sperm throughout the lumen of the seminal vesicle.  
Concentrations were visible surrounding spermatocytes in the final stages of meiosis, 
which reside in the distal region.  Lower levels were present throughout the seminal 
vesicle surrounding haploid spermatids (Figure 2.2F,G), though this pool of SWM-
1::mCherry was often difficult to detect.  We surmised that this might be due to lack of 
space between spermatids, which are tightly packed together.  To facilitate visualization 
of SWM-1::mCherry, we analyzed its localization in a spe-6(hc163) mutant, which 
contains sperm that activate independently of swm-1 (Muhlrad and Ward, 2002).  When 
activated sperm are present, the contents of the seminal vesicle are more disorganized, 
with empty spaces between cells.  In spe-6 males, SWM-1::mCherry was present 
throughout the entire seminal vesicle (supplementary data), indicating that it can spread 
throughout. 
Together with analysis of the transcriptional reporter, these data indicate that 
SWM-1 is produced in the somatic muscle and vas deferens cuboidal cells.  Furthermore, 
it is secreted from one or both of these tissues and can access the extracellular space 
around stored sperm.   
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SWM-1 and TRY-5 localize near sperm  
independently of each other 
 
 In the absence of SWM-1, TRY-5 is visible at elevated levels in the seminal 
vesicle (Smith and Stanfield, 2011).  Since both proteins are secreted into the 
extracellular space, a simple regulatory mechanism to envision is that SWM-1 inhibits 
TRY-5 activity via a direct interaction.  However, alternative models are that SWM-1 
might affect the localization, release, or stability of TRY-5.   
To address these models, we tested the possibility that TRY-5 and SWM-1 
regulate one another’s localization.  In a swm-1 mutant background, we observed TRY-
5::GFP in the seminal vesicle, as before (Smith and Stanfield, 2011); furthermore, we 
observed no obvious change in TRY-5::GFP , as might be predicted if SWM-1 were 
responsible for keeping TRY-5 levels low in this region.  Therefore, we tested if the 
apparent expansion of TRY-5::GFP into the seminal vesicle is due to the loss of swm-1, 
or rather if TRY-5::GFP protein is simply more evident when activated sperm are 
present.  To facilitate visualization of TRY-5 without disrupting endogenous SWM-1, we 
again utilized a spe-6 mutant that contains activated sperm.  We found that TRY-5::GFP 
spreads into the seminal vesicle of spe-6; swm-1(+) males, just as it does in spe-6; swm-
1(-) males (Figure 2.3A-F). 
We next compared the distributions of SWM-1::mCherry and TRY-5::GFP in 
wild-type animals.  SWM-1::mCherry was expressed broadly, completely surrounding 
the seminal vesicle in the pseudocoelom and also surrounding sperm in the seminal 
vesicle.  By contrast, TRY-5 is largely restricted to the vas deferens, both in the valve and 
in cuboidal cells, and is only present at low levels in the posterior of the seminal vesicle 
(Figure 2.3G,H).  Interestingly, we observed SWM-1 and TRY-5 co-localization in 
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cuboidal cells, suggesting that SWM-1, like TRY-5 is a seminal fluid protein (Figure 2.3 
I-L).  Lastly, in a try-5 mutant background, the distribution of SWM-1::mCherry showed 
no differences as compared to wild-type  (Figure 2.3M-P and Figure 2.2B-E). 
Thus, SWM-1 per se does not prevent the spread of TRY-5 into the seminal 
vesicle.  Rather, these data suggest a model in which TRY-5 is continually present in the 
seminal vesicle, though presumably at levels low enough to be inhibited by SWM-1. 
 
Muscle-derived SWM-1 regulates sperm  
activation within the gonad 
 
To understand how males prevent premature sperm activation, we sought to 
determine which source(s) of SWM-1 are required for this regulation.  We performed 
tissue-specific expression of SWM-1 and assayed for rescue of the premature activation 
phenotype of the swm-1(me87) null mutant.  We generated transgenic strains expressing 
SWM-1 or SWM-1::mCherry driven by either the vas deferens cuboidal cell-specific 
clec-197 promoter (“Pvas”) or the muscle-specific myo-3 promoter (“Pmyo”) (Thoemke 
et al., 2005) (Fire et al., 1990).   
When SWM-1 or SWM-1::mCherry was expressed only in the vas deferens 
cuboidal cells, it rescued the premature activation of young adult 24 hr post L4 swm-
1(me87) mutants (Figure 2.4A).  However, by 48 hr post L4, sperm were activated in 
most animals, indicating that this expression was not sufficient to inhibit activation later 
in adulthood (Figure 2.4A).  To determine if this partial rescue activity correlated with 
differential localization of SWM-1 in the seminal vesicle at early versus later stages, we 
examined Pvas::SWM-1::mCherry localization.  Beginning at the L4 stage, SWM-
1::mCherry was visible in the lumen between the cuboidal cells and seminal vesicle, 
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where it contacted spermatids (Figure 2.4B,C and supplementary data).  As expected, 
SWM-1::mCherry localized to cuboidal cell vesicles (Figure 2.4D,E) Interestingly, we 
also observed a low level of vas deferens-derived SWM-1::mCherry in coelomocytes, 
despite absence of expression in coelomocytes from this promoter (supplementary data), 
indicating that SWM-1::mCherry derived from the vas deferens can enter the body 
cavity.  Lastly, we observed SWM-1::mCherry in the seminal vesicle at low levels and at 
a low frequency (5-20% of animals) (supplementary data).  This variability was 
consistent with the lower rates of rescue we observed for this transgene, and we suspect 
that the rescue we observed at 24 hr post L4 is due to the vesicles being in contact with 
sperm early, at the L4 stage (Figure 2.4B,C).   
Surprisingly, when expressed in muscle, SWM-1 and SWM-1::mCherry strongly 
rescued activation in swm-1(me87) mutants (Figure 2.4A).  Pmyo::SWM-1::mCherry was 
present in body wall muscle, the body cavity, and coelomocytes at all stages analyzed 
(supplementary data) (Figure 2.4F,G).  Similar to its localization in SWM-1::mCherry 
knock-in animals, SWM-1::mCherry was present around developing and stored sperm in 
the seminal vesicle (Figure 2.4F,G).  Removing the secretion signal resulted in the 
accumulation of SWM-1::mCherry inside muscle cells and eliminated rescue (Figure 
2.4A, H-I).  These data suggest that muscle secrete SWM-1 into the body cavity, from 
where it enters the gonad to inhibit activation.   
We reasoned that if the gonad takes up SWM-1 from its surroundings, then 
secretion into the body cavity from an ectopic source might also be sufficient to inhibit 
activation.  To test this, we used a dpy-7 promoter to express SWM-1::mCherry from 
hypodermis, (“Phyp”), epithelial cells that encase the worm (Gilleard, 1997).  We found 
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that hypodermis-derived SWM-1::mCherry also rescued activation, although at reduced 
levels (Figure 2.4A).  Consistent with the low level of rescue, we observed hypodermis-
derived SWM-1::mCherry in the body cavity but not in the seminal vesicle (Figure 2.4J-
K, supplementary data).   
These experiments strongly support the model that extragonadal, muscle-derived 
SWM-1 is sufficient to inhibit precocious activation by being secreted into the body 
cavity where it can enter the seminal vesicle.  On the other hand, expression in the gonad 
is not sufficient, although it appears to contribute to regulation, perhaps via a similar 
route of delivery.   
 
 
Proteins move between the pseudocoelom and gonad 
We sought to determine whether movement of proteins between the soma and the 
germline environment was specific to SWM-1, or whether other secreted proteins could 
enter and exit the gonad.  To test this, we expressed secreted mCherry or secreted GFP in 
specific gonadal and extragonadal tissues, including hypodermis, muscle, neurons, and 
two regions of the vas deferens: cuboidal cells and valve cells.  To assess entry into the 
gonad, we scored for localization to the seminal vesicle lumen in spe-6 males, and to 
assess entry of proteins into the body cavity, we scored for localization in coelomocytes.   
We found that mCherry and GFP secreted from extragonadal muscle were present 
in the pseudocoelom and entered the gonad (Table 2.1).  As a functional test, we also 
expressed TRY-5::GFP outside the gonad and assayed its localization and ability to 
rescue the try-5(tm3813) null mutation.  Interestingly, TRY-5::GFP secreted from either 
muscle or neurons rescued activation in the seminal vesicle (Table 2.1).  Furthermore, we 
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found that the opposite direction of movement of proteins was possible: mCherry 
secreted from the somatic gonad can be detected in the body cavity.  Although we did not 
observe this gonad-to-pseudocoelom movement for GFP, these data show that the 
exchange of proteins between the gonad and other tissues is bidirectional and neither 
specific to SWM-1 nor limited to the sperm activation pathway.  In addition, they support 




SWM-1 is a seminal fluid protein 
Since SWM-1 is produced in cuboidal cells of the vas deferens, which release 
TRY-5 during mating (Figure 2.3I-L), we looked to see if SWM-1 might also be a 
component of seminal fluid.  The cuboidal cells contain a population of variably sized 
membrane-bound vesicles, which can be observed either using DIC or by visualizing 
TRY-5::GFP (Figure 2.3I,K).  We observed that SWM-1::mCherry and TRY-5::GFP 
both were present in these vesicles.  In a subset, they co-localized, but their relative levels 
varied (Figure 2.3I-L).  To test for transfer, we crossed [Pswm-1::swm-1::mCherry] 
males to wild-type hermaphrodites.  During mating, SWM-1::mCherry was secreted and 
transferred to the hermaphrodite, where it spread throughout the uterus (Figure 2.5A,B).  
Thus, SWM-1 is contributed to the migratory path of sperm via transfer in seminal fluid. 
 
 
SWM-1 is produced in muscle and enters the  
reproductive tract in hermaphrodites 
 
Previous work demonstrated that swm-1 is not required for hermaphrodite 
fertility, but is apparently present and functional (Stanfield and Villeneuve, 2006), so we 
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examined our swm-1 reporters in adult hermaphrodites.  For tissues that are present in 
both sexes, hermaphrodites appeared similar to males.  Pswm-1::mCherry::H2B was 
transcribed in body wall muscle cells (supplementary data), and SWM-1::mCherry was 
present at low levels in muscle as well as in the body cavity, where it was taken up into 
coelomocytes (supplementary data).  We also observed SWM-1 in the hermaphrodite 
gonad.  Pswm-1::mCherry::H2B was expressed in the spermathecae, the regions of the 
hermaphrodite gonad where sperm are stored (Figure 2.5C-D), and SWM-1::mCherry 
protein localized throughout the hermaphrodite reproductive tract.  Within the lumen of 
the spermatheca, it surrounded stored sperm (Figure 2.5E,F); it also was present 
throughout the uterus, among fertilized eggs.  As it can be difficult to distinguish between 
the body cavity and uterus, we used GFP-labeled seminal fluid to mark the lumen of the 
uterus.  swm-1(jn62[swm-1::mCherry] hermaphrodites mated to males expressing TRY-
5::GFP (Figure 2.5E-H) showed clear co-localization of SWM-1::mCherry and TRY-
5::GFP in the uterus.  Thus, SWM-1 is present throughout the sperm migratory 
environment in hermaphrodites.  Furthermore, as in males, SWM-1 is secreted into the 
body cavity and then taken up into the hermaphrodite gonad (data not shown). 
 Our data suggested that SWM-1 might have a postmating role in the sperm 
migratory environment.  Not only is it contributed to the uterus by both sexes, but its 
presence in the male gonad is dispensable for regulating activation within the male.  
Therefore, we sought to determine whether SWM-1 in the hermaphrodite uterus affects 
male fertility or sperm functions. 
Since it is transferred from the male in seminal fluid, we hypothesized that SWM-
1 is important for male sperm success.  Therefore, we used our strains expressing swm-1 
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in specific tissues to manipulate the level of SWM-1 provided by the hermaphrodite 
and/or male.  To create males that do not transfer SWM-1 (Vas-), we used [Pmyo-
3::swm-1]; swm-1(me87) males, in which muscle-derived SWM-1 rescues the sperm 
activation defect (Figure 2.4A,F,G).  To create males that transfer an elevated amount of 
SWM-1, we used [Pvas-3::swm-1]; swm-1(+) males (Vas++), in which SWM-1 is 
expressed from not only the wild-type locus, but also by the Pvas transgene.  To 
eliminate possible complications of hermaphrodite self fertility, we used a fog-2(q71) 
mutation to prevent sperm production in recipient hermaphrodites.  We found no 
difference in male fertility between wild-type males and either Vas++ or Vas- males 
crossed to swm-1(-) hermaphrodites (Figure 2.6A,B).  However, Vas++ males had 
increased fertility in crosses to swm-1(-) hermaphrodites as compared to crosses to swm-
1(+) hermaphrodites (Figure 2.6B).  Taken together, these results fail to demonstrate a 
requirement for SWM-1 in the hermaphrodite reproductive tract, but do suggest that high 
levels might decrease sperm success.  The significance of this result in vivo is unclear.  
Regardless, SWM-1 is clearly a major component of the seminal fluid that males transfer 
to hermaphrodites during mating. 
 
Discussion 
Regulation of sperm development by somatic tissues 
Sperm maturation is a critical developmental process regulated by cues derived 
from multiple somatic cell types.  Here we characterize the expression and protein 
localization of SWM-1, the negative regulator of C. elegans sperm activation.  We 
determined that it is produced by somatic body wall muscle and the vas deferens.  We 
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show that the source of SWM-1 in within the gonad, vas deferens cuboidal cells, 
contributes to regulating motility but is not sufficient to inhibit activation throughout 
adulthood.  Surprisingly, secretion of SWM-1 from extra-gonadal somatic muscle cells is 
sufficient to inhibit activation.  This finding, that a factor critical for fertility is derived 
from extra-gonadal muscle cells is unexpected.  While regulation of sperm development 
by factors secreted by the vas deferens or other somatic gonad cells is common in other 
organisms, a role for muscle in sperm development has not, to our knowledge, been 
identified.  However, our data contributes to an emerging body of work showing that 
muscle is an important source of secreted factors that act on various tissues and that the 
role of muscle goes beyond structure (Iizuka et al., 2014).  Myokines, factors secreted 
from muscle cells, have been shown to be important in tissues such as vasculature and 
bone.  Additionally, differentiation of Drosophila intestinal stem cells is regulated by 
factors secreted by smooth muscle (Lin et al., 2008).   
Using tissue-specific expression, we show that muscle-derived SWM-1 
accumulates in pools near sperm that have recently completed meiosis, similar to swm-
1::mCherry expressed from its native genomic locus.  By contrast, cuboidal cell-derived 
SWM-1::mCherry is not present in these pools.  Cuboidal cells are at the proximal end of 
the gonad, at some distance from newly developed spermatids, and do not complete 
development until after some sperm has accumulated.  Furthermore, it is interesting to 
note that proteins with a secretion signal expressed in the vas deferens are sequestered in 
large apical vesicles that are depleted during mating and little appears to be constitutively 
released, yet the same secreted proteins expressed in muscle are not sequestered but are 
continually secreted.  We speculate that perhaps production of SWM-1 by a cell type that 
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develops well before sperm is made, that does not sequester secreted proteins or get 
depleted upon mating, ensures that sufficient inhibitory signal is present immediately 
after sperm complete meiosis and become competent to activate.  This may be important 
for male fertility in wild populations as it has been shown that males that have mated 
display increased levels of activation as compared to virgins (Ward et al., 1983).  
Therefore, muscle as a source of inhibitory signal may help maintain a pool of non-
activated sperm and ensure fertility during multiple matings. 
Soma-germ line communication 
 Other proteins secreted from extra-gonadal tissues are critical for fertility.  For 
example, long-distance soma-to-germline transfer has been demonstrated in mice, in 
which the protease inhibitor Fetuin-B is secreted from the liver but required by oocytes to 
prevent premature zona pellucida hardening (Dietzel et al., 2013) (Denecke et al., 2003).  
In C. elegans, production and loading of yolk proteins into oocytes occurs via uptake 
from the body cavity, similar to SWM-1.  Yolk is produced in the intestine, secreted into 
the body cavity, and taken up by receptor-mediated endocytosis via a yolk protein 
receptor (Grant and Hirsh, 1999; Kimble and Sharrock, 1983).  Our findings differ in that 
movement of SWM-1::mCherry and other proteins into the gonad does not seem to 
require a specific transporter.  Further experiments to understand how SWM-1 physically 
enters the seminal vesicle would be interesting for understanding how these factors are 
exchanged. 
 Our investigation of SWM-1 demonstrates a curious phenomenon: systemic 
factors present in the body cavity can enter the gonad and, vice versa, factors produced in 
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the gonad can enter the body cavity.  By analyzing mCherry and GFP secreted from 
within the gonad and from outside the gonad, we demonstrated that this exchange is not 
specific to sperm activation proteins and that other proteins can also act this way, 
implying that exchange of factors is widespread.  This finding implies that sperm are 
exposed to a variety of factors in the pseudocoelom suggesting that sperm cells are robust 
in their ability to encounter many signaling environments.   
Regulation of sperm development by protease signaling 
Our analysis of the localization of SWM-1 and TRY-5 in combination is a step 
toward understanding the molecular mechanism by which they regulate sperm activation.  
By using spe-6 mutants, we showed that TRY-5 is able to spread into the seminal vesicle 
even in the presence of SWM-1.  We also showed that the opposite is true: localization of 
SWM-1 does not depend on TRY-5.  Furthermore, visualizing SWM-1::mCherry in 
combination with TRY-5::GFP suggests that males regulate activation mainly by 
expressing the activator and inhibitor in different domains; whereas TRY-5 is mainly 
sequestered in the vas deferens, SWM-1 is widespread, surrounding the entire seminal 
vesicle in the pseudocoelom where it can freely enter the gonad and keep activation in 
check.  It is interesting that SWM-1 and TRY-5 are in close proximity in the seminal 
vesicle.  This suggests that where TRY-5 does encounter SWM-1, they might directly 
interact. 
These data show that SWM-1 does not inhibit TRY-5 release from the valve.  
Instead, they support a model where TRY-5 is secreted into the seminal vesicle at a low 
basal rate that is not sufficient to activate sperm, due to the predominantly inhibitory 
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environment maintained by consistent secretion of SWM-1 from somatic muscle cells 
that surround the seminal vesicle.  Although these findings do not define the molecular 
mechanisms of SWM-1 and TRY-5, they are consistent with a direct interaction in the 
extracellular environment.  Indeed, in vitro biochemical analysis of recombinant SWM-1 
and TRY-5 activities would be interesting future work.  Nevertheless, these co-
localization studies highlight the utility of C. elegans as a model for studying the sperm 
signaling environment and measuring the production and release of seminal fluid proteins 
in the context of live animals. 
 
SWM-1 in the sperm migratory environment 
In the hermaphrodite, SWM-1 is present, yet its role has been elusive.  While it is 
known that swm-1 is functional in the hermaphrodite, it is dispensable for fertility 
(Stanfield and Villeneuve, 2006).  Our analysis of SWM-1::mCherry in males and 
hermaphrodites suggests that it is important in the sperm migratory environment as it is 
contributed both by males in seminal fluid and is also supplied by hermaphrodites to the 
uterus.  Using males that lack SWM-1 in the vas deferens but have SWM-1 in muscle to 
inhibit premature activation, we showed that male fertility is not affected by SWM-1 in 
seminal fluid but is affected by hermaphrodite SWM-1.  Although our experiments failed 
to identify a definitive role for SWM-1 in the hermaphrodite reproductive tract, it is 
possible that our assay was not sufficiently sensitive to detect an effect of SWM-1.  
Given that SWM-1 plays a critical role for male but not hermaphrodite fertility, perhaps 
its effect in the uterus on fertility is subtle and its role may only be uncovered in more 
stringent conditions such as when sperm from multiple males compete.   
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In summary, these studies have uncovered a critical yet surprising role for muscle 
in the regulation of C. elegans sperm development.  Additionally, this work demonstrates 
that there is significant communication between extragonadal tissues and the gonad in 
both males and hermaphrodites, which has implications for understanding not only sperm 
activation but virtually every reproductive process in the adult.   
 
Materials and methods 
C. elegans genetics 
C. elegans were grown at 20ºC on nematode growth medium seeded with 
Escherichia coli strain OP50 and were derived from the wild-type Bristol N2 strain 
(Brenner, 1974).  To obtain males, the him-5(e1490) allele was present in all strains 
where males were analyzed, including wild-type controls (Hodgkin et al., 1979).  
Recombination was used to introduce the him-5(e1490) allele into the swm-1(jn60[swm-
1(EEtoVK)::mCherry]) strain.  Other alleles used for experiments were ttTi5605, dpy-
18(e364), spe-6(hc163), unc-119(ed3), cxTi10816, dpy-11(e224), try-5(tm3813), swm-
1(me87), fog-2(q71), and ajm-1::GFP (r-Jensen et al., 2008) (Frøkjær-Jensen et al., 2012) 




Mos-mediated single-copy insertion (MosSCI) was used to integrate transgenes at the 
ttTi5605 II and cxTi10816 IV loci as described by Frokjaer-Jensen (r-Jensen et al., 2008) 




MosSCI donor constructs were generated using the MultiSite Gateway Three-
fragment Vector Construction Kit (Thermo Fisher Scientific).  Fragments were 
recombined into the pCFJ150 or pCFJ212 destination vectors for transgene insertion on 
chromosome II or IV, respectively (r-Jensen et al., 2008).  A description of fragments 
used for generating targeting constructs is listed in the supplementary data and primers 
used to generate donor vector fragments are listed in the supplementary data. 
To select an appropriate swm-1 promoter, we generated transgenes that included 
different lengths of sequence 5’ and 3’ to the swm-1 coding region and assayed their 
ability to rescue swm-1(me87), a null allele.  Transgenes containing 1.3 kb of 5’ sequence 
and 0.7 kb of downstream sequence showed strong levels of rescue of the premature 
activation phenotype (supplementary data).  However, 0.7 kb of 5’ sequence and 0.2 kb 
of 3’ sequence regions showed greatly reduced rescue (data not shown). 
 
Molecular biology 
MosSCI donor constructs were generated using the MultiSite Gateway Three-
fragment Vector Construction Kit (Thermo Fisher Scientific) to recombine three vector 
fragments into the pCFJ150 or pCFJ212 for transgene insertion on chromosome II or IV 
respectively.  pCFJ150, pCFJ212 and the body wall muscle promoter vectors P2305 and 
pPM4 containing the myo-3 promoter described by Fire et al. 1990 were gifts from E.  
Jorgensen.  The PADA96 vector containing the dpy-7 promoter was a gift from L. 
Johnstone.  The mCherry and GFP tagged H2B vectors pCM1.51, pCM1.35 and 
pCM5.37 were gifts from G. Seydoux (Merritt et al., 2008).  A description of fragments 
used for generating targeting constructs is listed in the supplementary data and primers 
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used to generate donor vector fragments are listed in supplementary data. 
 
CRISPR/Cas9 genome editing 
The co-CRISPR technique described by Kim et al. (2014) and Arribere et al., 
(2014) was adapted to insert mCherry into the endogenous swm-1 locus.  N2 
hermaphrodites were injected with DNA fragments for expression of swm-1 guide RNA5 
and C25E10.8 guide RNA3 along with thepJA42 and AF-JA-53 reagents for rol-6 co-
CRISPR selection (Arribere et al., 2014)., Simultaneously, we provided a linear DNA 
repair template to introduce mCherry coding sequences immediately before the swm-1 
stop codon, two silent PAM site mutations to prevent Cas9 re-cutting and 114-124 bp 
homology arms.  Guide RNA DNA fragments were generated by fusion PCR as 
described by Ward 2015 and pJW1259 (Cas9 expression vector; Ward, 2015).  The repair 
template was amplified with Phusion (New England Biolabs) and purified with the 
Thermo Fisher PureLink PCR purification kit.  PCR assays were used to confirm 
integration of mCherry, followed by sequencing 3390 bp upstream of the swm-1 guide 
RNA5 cut site and 263 bp downstream of the C25E10.8 guide RNA cut site.  The him-
5(jn64) allele was generated using him-5 gRNA1 and him-5 gRNA3 to induce deletions 
at the him-5 locus in the swm-1(jn62[swm-1::mCherry]). 
 
Quantification of sperm activation 
Sperm activation was quantified by collecting virgin males as L4 larvae, 
incubating them at 20°C for 24 hr or 48 hr, and examining the seminal vesicle region 
using differential interference contrast (DIC) microscopy.  Each animal was scored as 
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“non-Activated,” if it contained only spermatids without visible pseudopods; “sperm + 
spermatids,” if we observed sperm with and without pseudopods; and “Activated,” if all 
sperm within the seminal vesicle had developed pseudopods.  For DIC, we used an 
AxioImager M1 microscope equipped with an AxioCam MRm (Zeiss).  Confocal images 
were acquired using an Olympus FV1000 microscope. 
Male fertility assays 
Males and hermaphrodites were collected as L4 larvae, incubated at 20°C for 24 
hr, and placed together in a 1:1 ratio for 24 hours to allow for mating.  Males were then 
removed and hermaphrodites were transferred to fresh plates every 24 hr for 4 additional 
days.  Matings that produced fewer than 150 total offspring or where offspring were not 
produced for at least three transfers were excluded from analysis.  dpy-11(e224) swm-
1(me87) fog-2(q71) animals are both male- and hermaphrodite-sterile, so dpy-11(e224) 
swm-1(me87) fog-2(q71)/dpy-11(e224) swm-1(jn62[swm-1::mCherry]) fog-2(q71) 
heterozygotes were maintained and hermaphrodites lacking mCherry were selected for 
assays.  The dpy-11(e224) fog-2(q71) homozygous strain was maintained by crossing 
males to hermaphrodites. 
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Figure 2.1 swm-1 is expressed in the somatic gonad and posterior muscle cells.  
Transmitted-light and confocal images of jnSi130[Pswm-1::mCherry::H2B] 24 hr adult 
males.  Ventral views are shown.  (A,B) swm-1 is expressed in vas deferens cuboidal 
cells.  Arrows indicate cuboidal cell nuclei.  (C,D) swm-1 is expressed in body wall 
muscle (arrowheads) and male-specific diagonal muscle (open arrowheads).  (E,F) Co-
localization with the muscle-specific transcriptional reporter 
jnSi226[Pmyo::GFP::H2B].  Labels: sv, seminal vesicle; vl, valve; cb, vas deferens 








Figure 2.2 SWM-1::mCherry localizes to the somatic gonad, muscle, and seminal 
vesicle.  (A) Quantification of sperm activation of swm-1(jn62[swm-1::mCherry]) and 
swm-1(jn60[swm-1(EEtoVK)::mCherry]) 24 hr post L4 adult males.  Males contain either 
nonactivated (light grey) a mix of sperm and spermatids (grey) or activated sperm 
(black).  Premature activation is increased in swm-1(jn60) males as compared to swm-
1(jn62) n = 24-50.  (B-I) Transmitted-light and confocal images of swm-1(jn62) 24 hr 
post L4 males.  (B,C) SWM-1::mCherry localizes to muscle cells overlying the male 
gonad.  (D,E) SWM-1::mCherry localizes to intracellular vesicles within a subset of vas 
deferens cuboidal cells.  (F,G) SWM-1::mCherry surrounds the seminal vesicle in the 
pseudocoelom (open arrowheads) and is concentrated in areas  near newly developed 
spermatids (arrowheads).  (H,I) SWM-1::mCherry accumulates in coelomocytes.  Labels: 
mei, meiotic region; sv, seminal vesicle; vl, vas deferens valve cells; and cu, vas deferens 






































Figure 2.3 SWM-1 and TRY-5 do not regulate localization of each other.  (A-H) 24 
hr post L4 adult males carrying the jnSi92[TRY-5::GFP] transgene in spe-6(hc163) and 
swm-1(me87) mutant backgrounds.  Outlined regions indicate the seminal vesicle.  n = 
20-25.  Scale bar, 25 µm.  (A,B) spe-6; jnSi92[TRY-5::GFP]; swm-1(+) male seminal
vesicle.  TRY-5::GFP spreads into the seminal vesicle independently of swm-1.  TRY-
5::GFP surrounds sperm in the anterior region of the seminal vesicle.  (C,D) spe-6;
jnSi92[TRY-5::GFP]; swm-1(-) male seminal vesicle.  TRY-5::GFP similarly spreads
into the seminal vesicle surrounding sperm in the anterior region.  (E-H) Control spe-6(+)
animals show normal TRY-5::GFP localization.  (E,F) swm-1(+) control male.  (G,H)
swm-1(me87) male.  (I-N) animals heterozygous for the MosSCI transgenes of SWM-
1::mCherry and TRY-5::GFP.  (I,J) pseudocoelomic SWM-1::mCherry surrounds the
seminal vesicle and is present throughout the seminal vesicle while TRY-5::GFP is
sequestered in the valve region.  (K-N) SWM-1::mCherry and TRY-5::GFP co-localize in
vas deferens cuboidal cell vesicles.  (O-R) jnSi193[Pswm-1::swm-1::mCherry]; swm-
1(me87) try-5(tm3813) males.  Localization of SWM-1::mCherry is normal in try-























Figure 2.4 Secretion of muscle-derived SWM-1 is sufficient to rescue activation. (A) 
Quantification of the sperm activation of 24 and 48 hr post L4 swm-1(me87) males 
carrying cuboidal cell, muscle or hypodermis-specific SWM-1, or SWM-1::mCherry 
transgenes.  Males contain either, nonactivated (light grey), a mix of sperm and 
spermatids (grey), or nonactivated (black) sperm n = 20-47.  (B-E) [Pclec-197::swm-
1::mCherry]; swm-1(me87) males.  (B,C) SWM-1::mCherry is near sperm in L4 males.  
Outlined region indicates the seminal vesicle.  Arrow indicates SWM-1::mCherry in 
close proximity to sperm. (D,E) Cuboidal cell-specific SWM-1::mCherry in 24 hr post L4 
males.  (F,G) [Pmyo::swm-1::mCherry]; swm-1(me87) 24 hr post L4 adult male.  Muscle 
cell-specific SWM-1::mCherry is present in the pseudocoelom and in the seminal vesicle 
surrounding sperm.  Arrow indicates concentrations of SWM-1::mCherry surrounding 
sperm that have recently completed meiotic division.  Open arrowhead indicates SWM-
1::mCherry in the pseudocoelom.  Coelomocyte, cc.  (H,I) [Pmyo::SS∆::swm-
1::mCherry]; swm-1(me87) adult male.  SWM-1::mCherry is sequestered in muscle and 
sperm are activated.  Arrowheads indicate activated sperm cells.  (J-M) [Phyp::swm-
1::mCherry]; swm-1(me87) adult male.  (J-K) Hypodermis-derived SWM-1::mCherry is 
not detectable in the seminal vesicle.  (L,M) Hypodermis-derived SWM-1::mCherry is 









Figure 2.5 SWM-1 is present in the hermaphrodite uterus.  (A,B) Uterus of a 24 hr 
post L4 adult hermaphrodite that has mated with a jnSi193[Pswm-1::swm-1::mCherry]; 
swm-1(me87) male.  Males contribute SWM-1 to the hermaphrodite uterus in seminal 
fluid.  Male-derived SWM-1::mcherry is present between fertilized eggs in the 
hermaphrodite uterus.  (C,D) jnSi130[Pswm-1::mCherry::H2B] 24 hr post L4 
hermaphrodite.  swm-1 is expressed in spermathecal cells.  (E-H) Uterus of 24 hr post L4 
swm-1(jn62[swm-1::mCherry]) hermaphrodite after mating with a jnSi92[Ptry-5::try-
5::gfp]; swm-1(me87) try-5(tm3813) male.  SWM-1::mCherry co-localizes with male 
seminal fluid in the hermaphrodite uterus.  SWM-1::mCherry is present in the 
spermatheca surrounding stored sperm.  Regions of the hermaphrodite reproductive tract 

















































































































































































































































































































































































Table 2.1 Proteins can move into and out of the gonad.  Protein localization of 
secreted mCherry, GFP, SWM-1::mCherry and TRY-5::GFP expressed under different 
promoters in extragonadal tissues (muscle, hypodermis, or neurons) or gonadal vas 
deferens cells (valve or vas deferens).  Presence (+) or absence (-) of localization to the 













































Figure 2.S1 Single-copy insertion swm-1 transgenes rescue the premature sperm 
activation of swm-1(me87) null mutants.  Quantification of sperm activation phenotype 
of transgenic males carrying either swm-1 or swm-1::mCherry single-copy insertion 














Figure 2.S2 CRISPR design and subcellular SWM-1 localization.  (A) Schematic of 
CRISPR strategy to generate genomic swm-1::mCherry.  Arrowheads indicate Cas9 cut 
sites.  The repair template included 114 bp of sequence 5’ to the swm-1 gRNA cut site, 
mCherry fused to the C-terminus of swm-1, 124 bp of sequence 3’ to the C25E10.8 
gRNA cut site, and two silent PAM site mutations.  (B,C) Images of a 24 hr post L4 swm-
1(jn60[swm-1(EEtoVK)::mCherry]) adult male.  SWM-1 accumulated in somatic body 
wall muscle cells (arrowheads) and male-specific diagonal tail muscle cells (open 
arrowheads).  (D,E) Images of a 24 hr post L4 swm-1(jn62[swm-1::mCherry]) adult male 
with the apical membrane marker AJM-1::GFP.  SWM-1::mCherry-containing vesicles 














Figure 2.S3 SWM-1 is present in hermaphrodite muscle and pseudocoelom.  A) Co-
localization of [Pswm-1::mCherry::H2B] with [Pmyo::GFP::H2B].  swm-1 is expressed 
in body wall muscle.  B-F) swm-1(jn62[SWM-1::mCherry] 24 hour hermaphrodite 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2.S4 List of DNA sequences targeted for CRISPR editing    
gene guide RNA Target sequence (PAM) 
C25E10.8 gRNA3 GATCACTGTGAGACACAATG(CGG) 
swm-1 gRNA5 GCACGATACCAGCTCCTCAT(TGG) 
him-5 gRNA1 GATGAACAACGAAAAACAGT(TGG) 






GENETIC ANALYSIS OF SWM-1 TRYPSIN INHIBITOR-LIKE DOMAINS  
 
Introduction 
Serine protease inhibitors are important in a wide variety of cellular processes.  
For example in humans, serine protease inhibitors are critical for regulating proteolysis 
involved in blood coagulation, inflammation, sperm maturation, and cell migration  
(Huntington, 2011) (Poiani, 2006) (Torriglia et al., 2017).  One class of serine protease 
inhibitor that has not been extensively studied are the low molecular weight trypsin 
inhibitor-like (TIL) domain proteins.  TIL domains are characterized by 10 conserved 
cysteine residues that form 5 disulfide bridges important for folding and a 3-4 amino acid 
reactive site where the inhibitor is cleaved by serine proteases (Babin et al., 1984; Chen 
et al., 2013; Di Cera, 2009; Peanasky et al., 1984a; Peanasky et al., 1984b).  These 
protease inhibitors have been found in frog skin secretions, Drosophila seminal fluid, 
honeybee hemolymph, and scorpion venom (Lung et al., 2002;  Peanasky et al., 1984b; 
Rosengren et al., 2001;  Zeng et al., 2013).  They are also present in larger proteins in 
humans, including otogelin-like and von Willebrand factor (vWF) (Bonnet et al., 2013; 
Zhou et al., 2012).  Importantly, mutations in the TIL domains of vWF cause the blood 
clotting disorder Von Willebrand disease (Shiltagh et al., 2014).  Given their role in a 
large variety of cellular processes, the study of TIL domains has broad implications in of 
reproductive biology, blood coagulation and parasitology.      
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SWM-1 may inhibit two proteases 
In C. elegans, the negative regulator of sperm activation, SWM-1, contains two 
TIL domains.  The swm-1(me87) null mutation causes premature sperm activation, while 
two other mutants, swm-1(me86) and swm-1(me66), are partial loss of function alleles 
isolated in a noncomplementation screen looking for additional swm-1 alleles (Stanfield 
and Villeneuve, 2006).  The me66 allele affects the N-terminal TIL domain (N-TIL) 
while the me86 allele affects the C-terminal TIL domain (C-TIL), and both are missense 
mutations.  Interestingly, trans-heterozygous me66/me86 animals show reduced levels of 
premature activation as compared to either homozygote (Stanfield and Villeneuve, 2006).  
This indicates that the two alleles partially complement each other.  Furthermore, the 
reactive sites of the TIL domains are divergent (Stanfield and Villeneuve, 2006), 
suggesting that SWM-1 may inhibit two distinct proteases.   
While analysis of the me86 and me66 mutants suggests SWM-1 may have two 
targets, the two mutations are not equivalent and likely have different effects on TIL 
domain structure and/or catalytic activity.  In the N-TIL, the me86 mutation affects an 
amino acid adjacent to the 7th conserved cysteine (C7) important for structure, while in 
the C-TIL, me66 affects the first conserved cysteine (C1).  Therefore, understanding the 
function of each domain requires further investigation.  A more detailed analysis of 
individual SWM-1 TIL domains will aid in understanding the molecular mechanism by 
which SWM-1 acts and determine whether SWM-1 may have multiple targets.  In this 
chapter, I describe my investigation of the role of individual TIL domains in inhibiting 





To determine whether one or both TIL domains were required to inhibit 
activation, I analyzed single TIL domain transgenic animals using the MosSCI technique 
to generate single copy-insertion transgenes at the ttTi5605 locus (r-Jensen et al., 2008).  
As a control, I also analyzed animals with a full-length swm-1 transgene that included 
both TIL domains.  As a readout of TIL function, I analyzed the seminal vesicles of adult 
transgenic males in the swm-1(me87) null background to determine whether they were 
filled with nonactivated sperm, a mixture of sperm and spermatids, or only activated 
sperm.  I looked at two time points when males are healthy adults and have accumulated 
a significant amount of sperm.  I found that the single N-TIL transgene failed to rescue 
activation at 24 and 48 hours post L4.  However, the single C-TIL transgene partially 
rescued the premature sperm activation of swm-1(me87) null mutants in 24 hour but not 
48 hour post L4 adults (Figure 3.1).  Importantly, the full-length control exhibits full 
rescue of the null at both 24 and 48 hours.  This suggests that neither TIL domain alone is 
sufficient to inhibit activation, but the C-terminal TIL domain plays a more significant 
role in inhibiting activation. 
To further test the requirement for the TIL domains, I also analyzed their ability 
to rescue the weaker alleles of swm-1, me66, and me86.  In the swm-1(me86) mutant 
background, both N-TIL and C-TIL transgenes showed strong rescue at 24 hours and 
partial rescue at 48 hours post L4.  In the swm-1(me66) mutant background, both 
transgenes showed strong rescue at 24 hours post L4 and no rescue at 48 hours post L4.  
Together these results suggest that the C-terminal TIL domain might play a more 
significant role in inhibiting activation, but both domains exhibit inhibitory activity.  
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Additionally, the analysis of the weak alleles suggests that the domains can compensate 




This analysis of SWM-1 TIL domains suggest that they are not equivalent in their 
role of inhibiting sperm activation.  While these results further support the idea that 
SWM-1 may have multiple targets, they leave ambiguity as to how SWM-1 functions at 
the molecular level.  Whereas introduction of the C-TIL partially inhibits activation of 
swm-1 null mutants, introduction of the N-TIL does not, suggesting that the C-TIL may 
play a more significant role in activation, although is not sufficient for full regulation.  
Furthermore, in the swm-1(me86) and swm-1(me66) genetic backgrounds, the presence of 
a C-TIL mutation appears to be more damaging than the N-TIL mutation, regardless of 
which transgene was introduced.  The fact that either transgene exhibited similar levels of 
rescue of the weak alleles also suggests that the domains can partially compensate for 
each other.   
 Understanding the molecular mechanism by which SWM-1 inhibits activation 
would be aided by targeted mutations that affect each TIL domain equally, identification 
of downstream SWM-1 targets, and/or in vitro biochemical assays.  Targeted mutations 
should carefully consider previous biochemical analysis of TIL domains.  Specifically, in 
a study by Chen et al. (2013), chimeras were made of SjAPI, a TIL domain protein that is 
present in scorpion venom.  In this study, researchers used SjAPI as a scaffold and 
created recombinant proteins, replacing reactive residues with those of other scorpion 
venom TIL proteins with a known substrate.  They found that replacement of the reactive 
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site alone is not sufficient to target a substrate in the SjAPI chimera (Chen et al., 2013).  
This indicates that substrate specificity of TIL domains is determined not only by the 
reactive site but also by other, unknown characteristics of the protein.  Given these 
findings, interpretation of targeted mutation analysis may be challenging and focusing on 
generating mutations in the conserved cysteines important for folding rather than ablating 
substrate binding in the reactive site may be more likely to shed light on the molecular 
mechanism.   
 Perhaps more fruitful approaches would be to find additional genes in the sperm 
activation pathway and to test SWM-1 for protease inhibitory activity in vitro.  While it is 
known that TRY-5 and the SLC6 family protein SNF-10 are downstream of SWM-1, it 
remains unknown whether any of these proteins directly interact with each other (Fenker 
et al., 2014; Smith and Stanfield, 2011).  Furthermore, a SWM-1 suppressor screen 
resulted in the identification of at least 4 genes that suppress premature activation of 
swm-1(me86) mutants, but do not complement try-5 or snf-10.  Preliminary analysis of 
swm-1 suppressor strains can be found in chapter 4 of this dissertation.   
 Why would sperm activation be dependent on two TIL domains?  Of the known 
TIL domain-containing proteins, many contain only a single TIL domain.  Perhaps in the 
case of sperm activation, the presence of two TIL domains demonstrates the importance 
of the process of activation.  Indeed, SWM-1 is well conserved among closely and 
distantly related species of Caenorhabditis that utilize both androdioecious 
(male/hermaphrodite) and gonochoristic (male/female) systems of sex determination 
(Wei et al., 2014).  Furthermore, duplication of TIL domains is common and likely 
represents a means of genetic innovation, which is important for sexually reproducing 
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animals where sperm must survive in a different individual and compete for fertilization 
with other sperm (Zeng et al., 2013).   
 
 
Materials and methods 
Strains used 
Targeting constructs were injected into the EG6699: ttTi5605; unc-119(ed3)III 
strain.  To obtain males, the him-5(e1490) allele was present in all strains analyzed.  
Other alleles were swm-1(me87), swm-1(me86), and swm-1(me66). 
 
Cloning single TIL domains into expression vectors 
Generation of donor constructs and cloning into the PCFJ150 destination vector 
were performed as described in Chapter 2 Materials and methods.  Primers used for 
generating constructs are listed in Table 3.1 and a description of plasmids used to 
generate targeting vectors is in Table 3.2 
 
 
Quantification of sperm activation 




I would like to thank Angela Snow for generating targeting vectors of single TIL 







Babin, D.  R., Peanasky, R.  J.  and Goos, S.  M.  (1984).  The isoinhibitors of 
chymotrypsin/elastase from Ascaris lumbricoides: the primary structure.  Arch. 
Biochem. Biophys. 232, 143–161. 
Bonnet, C., Louha, M., Loundon, N., Michalski, N., Verpy, E., Smagghe, L., Hardelin, J.-
P., Rouillon, I., Jonard, L., Couderc, R., et al.  (2013).  Biallelic nonsense mutations 
in the otogelin-like gene (OTOGL) in a child affected by mild to moderate hearing 
impairment.  Gene 527, 537–540. 
Chen, Z., Wang, B., Hu, J., Yang, W., Cao, Z., Zhuo, R., Li, W.  and Wu, Y.  (2013).  
SjAPI, the first functionally characterized Ascaris-type protease inhibitor from 
animal venoms.  PLoS ONE 8, e57529. 
Di Cera, E.  (2009).  Serine proteases.  IUBMB Life 61, 510–515. 
Fenker, K.  E., Hansen, A.  A., Chong, C.  A., Jud, M.  C., Duffy, B.  A., Norton, J.  P., 
Hansen, J.  M.  and Stanfield, G.  M.  (2014).  SLC6 family transporter SNF-10 is 
required for protease-mediated activation of sperm motility in C. elegans.  Dev.  Biol.  
393, 171–182. 
Huntington, J.  A.  (2011).  Serpin structure, function and dysfunction.  J.  Thromb.  
Haemost.  9 Suppl 1, 26–34. 
Lung, O., Tram, U., Finnerty, C.  M., Eipper-Mains, M.  A., Kalb, J.  M.  and Wolfner, 
M.  F.  (2002).  The Drosophila melanogaster seminal fluid protein Acp62F Is a 
protease inhibitor that is toxic upon ectopic expression.  Genetics 160, 211–224. 
Peanasky, R.  J., Bentz, Y., Homandberg, G.  A., Minor, S.  T.  and Babin, D.  R.  
(1984a).  The isoinhibitors of chymotrypsin/elastase from Ascaris lumbricoides: the 
reactive site.  Arch. Biochem. Biophys. 232, 135–142. 
Peanasky, R.  J., Bentz, Y., Paulson, B., Graham, D.  L.  and Babin, D.  R.  (1984b).  The 
isoinhibitors of chymotrypsin/elastase from Ascaris lumbricoides: isolation by 
affinity chromatography and association with the enzymes.  Arch. Biochem. Biophys. 
232, 127–134. 
Poiani, A.  (2006).  Complexity of seminal fluid: a review.  Behav. Ecol. Sociobiol. 60, 
289–310. 
Jensen, C.  F.  O.  K.  A., Davis, M.  W., Hopkins, C. E., Newman, B.  J., Thummel, J.  
M., Olesen, S.  O.  R.-P., Grunnet, M.  and Jorgensen, E.  M.  (2008).  Single-copy 
insertion of transgenes in Caenorhabditis elegans.  Nat.  Genet.  40, 1375–1383. 
Rosengren, K.  J., Daly, N.  L., Scanlon, M.  J.  and Craik, D.  J.  (2001).  Solution 
structure of BSTI: a new trypsin inhibitor from skin secretions of Bombina bombina.  
Biochemistry 40, 4601–4609. 
  
70 
Shiltagh, N., Kirkpatrick, J., Cabrita, L.  D., McKinnon, T.  A.  J., Thalassinos, K., 
Tuddenham, E.  G.  D.  and Hansen, D.  F.  (2014).  Solution structure of the major 
factor VIII binding region on Von Willebrand factor.  Blood 123, 4143–4151. 
Smith, J.  R.  and Stanfield, G.  M.  (2011).  TRY-5 is a sperm-activating protease in 
Caenorhabditis elegans seminal fluid.  PLoS Genet.  7, e1002375. 
Stanfield, G.  M.  and Villeneuve, A.  M.  (2006).  Regulation of sperm activation by 
SWM-1 is required for reproductive success of C. elegans males.  Curr.  Biol.  16, 
252–263. 
Torriglia, A., Martin, E.  and Jaadane, I.  (2017).  The hidden side of 
SERPINB1/Leukocyte Elastase Inhibitor.  Semin. Cell & Dev. Biol. 62, 178–186. 
Wei, Q., Zhao, Y., Guo, Y., Stomel, J., Stires, R.  and Ellis, R.  E.  (2014).  Co-option of 
alternate sperm activation programs in the evolution of self-fertile nematodes.  Nat. 
Commun. 5, 5888. 
Zeng, X.-C., Liu, Y., Shi, W., Zhang, L., Luo, X., Nie, Y.  and Yang, Y.  (2013).  
Genome-wide search and comparative genomic analysis of the trypsin inhibitor-like 
cysteine-rich domain-containing peptides.  Peptides. 53, 106-114. 
Zhou, Y.-F., Eng, E.  T., Zhu, J., Lu, C., Walz, T.  and Springer, T.  A.  (2012).  





































































































































































































































































































































































































































































































































Table 3.1 Description of targeting vectors used to generate transgenic strains 
strains 









Pswm-1::swm-1::swm-1 3’ region pAKS1 pAKS2 pAKS3 pCFJ150 ttTi5605
Pswm-1::swm-1::swm-1 3’ region pAKS1 pAKS2 pAKS3 pCFJ150 ttTi5605

















































































































































































































































































































































































































































































































































































































The final step of C. elegans spermatogenesis, called sperm activation, is a 
dramatic cellular differentiation process involving remodeling of the cell in response to 
external signals.  During activation, membrane protrusions dynamically spike from the 
spherical cell, cellular contents are reorganized, and specialized organelles called 
membranous organelles (MO) fuse with the plasma membrane (reviewed in L'Hernault, 
2009).  The resulting fully mature spermatozoon is a polarized cell with a pseudopod that 
it uses to crawl and to migrate towards eggs.  In C. elegans, both males and 
hermaphrodites produce sperm, yet activation is regulated differently in each sex in terms 
of the location of activation and also the signaling molecules that regulate the process.  
An effort to understand C. elegans sperm activation at the molecular level has been the 
focus of several research groups and has revealed both novel and conserved aspects of 
reproductive biology, sperm biology, and cellular motility (reviewed in Ellis et al., 2014).  
In this chapter, I describe analysis of new genes important for sperm activation, including 
mapping and testing of candidate genes.  Although this investigation was unsuccessful in 
identifying specific genes that regulate sperm activation, it generated whole-genome 
sequencing data for several mutants, produced candidate gene deletion alleles using 
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CRISPR, and useful information to consider for future work.   
 
 
Activation of sperm by extracellular cues 
Like the sperm of most species, the final steps of C. elegans spermatogenesis 
require extracellular signals.  These are different in males and hermaphrodites.  Within 
males, sperm remain nonactivated until they are transferred to the hermaphrodite during 
mating and become activated in response to seminal fluid.  The seminal fluid activating 
factor is the serine protease TRY-5, which is produced in the vas deferens.  The protease 
inhibitor SWM-1 is produced in somatic body wall muscle as well as in the vas deferens 
and is required to inhibit premature sperm activation in males (Smith and Stanfield, 2011; 
Stanfield and Villeneuve, 2006) (Chapter 2).  While it is known that SWM-1 and TRY-5 
are required for this regulation, the molecular mechanism by which SWM-1 and TRY-5 
act are largely unknown.  In hermaphrodites, sperm activates upon entrance to the sperm 
storage organ called the spermatheca.  Hermaphrodites use a group of genes termed the 
spe-8 group to regulate activation.  Zinc is sufficient to activate sperm in a spe-8-
dependent manner, although how zinc acts through spe-8 group genes remains unknown 
(Liu et al., 2013).   
 The male and hermaphrodite sperm activation pathways are redundant; that is, the 
sperm from both sexes can respond to activators of the other sex, or undergo “trans-
activation.”  This has been shown in two sets of experiments.  First, spe-8 mutant 
hermaphrodite fertility can be restored by mating to wild-type males (Argon and Ward, 
1980).  Second, try-5 mutant male sperm can respond to the hermaphrodite activator 
(Smith and Stanfield, 2011).  Together, these results indicate that there are two 
  
76 
redundant, separable modes of sperm activation.  Studies of the sperm activation 
pathways have shown that the ancestral species of C. elegans had both the swm-1/try-5 as 
well as the spe-8 pathway (Wei et al., 2014), indicating the C. elegans species retained 
both modes of activation.  C. elegans sperm also can be induced to activate in vitro with 
Pronase (a mixture of proteases), monensin (an ionophore), triethanolamine (TEA, a 
weak base), 4,4’-diisocyanatostilbene-2,2’-disulfonic acid (DIDS, a chloride channel 
inhibitor), calmodulin inhibitors, wortmannin, or zinc, although the mechanism by which 
these activators work is unknown (Bae et al., 2009; Machaca et al., 1996; Nelson and 
Ward, 1980; Shakes and Ward, 1989; Ward et al., 1983). 
 
 
Sperm cell response to activation cues 
On the surface of the sperm cell membrane, the solute carrier 6 family 
transmembrane protein SNF-10 is required for activation by TRY-5.  snf-10 is a 
component of the male pathway and snf-10 mutant sperm can be transactivated in 
hermaphrodites (Fenker et al., 2014).  In the hermaphrodite pathway, SPE-12, SPE-19 
and SPE-29 are proteins that all have transmembrane domains and are predicted to act in 
a complex (Geldziler et al., 2005; Nance et al., 1999; Nance et al., 1999).  Additional 
SPE-8 group genes include the nonreceptor tyrosine kinase gene spe-8, the novel protein 
spe-27, and spe-47, which encodes a protein predicted to interact with the sperm motility 
and signaling protein MSP (major sperm protein) (LaMunyon et al., 2015; Minniti et al., 
1996; Muhlrad et al., 2014).  Following receipt of the activation cue, downstream 
intracellular events proceed, including fusion of MOs with the plasma membrane and 
pseudopod formation (reviewed in Fraire-Zamora and Cardullo, 2010). 
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Identification of additional sperm activation factors 
Although several components of each sperm activation pathway are known, the 
molecular mechanism by which they act to trigger differentiation is largely unknown.  In 
the male, it is likely that SWM-1 and TRY-5 directly interact as SWM-1 is a serine 
protease inhibitor and TRY-5 is a serine protease.  However, this has yet to be 
definitively shown.  Furthermore, SWM-1 has two trypsin inhibitor-like domains and 
analysis of these domains suggests that it may have more than one target (Stanfield and 
Villeneuve, 2006) (Chapter 3).  Therefore, it is possible that an unknown protease 
downstream of SWM-1 plays a role in the sperm activation pathway (Figure 4.1A).  
Another unknown in the male pathway is whether the sperm cell directly interacts with 
the TRY-5 protease.  Indeed, it is unknown whether TRY-5 and SNF-10 directly interact 
and it is possible that another factor is required to transduce the TRY-5 signal (Figure 
4.1A).   
 While try-5 and snf-10 were identified in a swm-1 suppressor screen seeking to 
identify genes that suppressed the swm-1 null phenotype, other factors could have been 
missed due to redundancy in the pathway.  Therefore, a screen using the weak alleles of 
swm-1 may uncover additional factors.  This screen could yield factors downstream of 
swm-1 that mediate transduction of the TRY-5 activation signal either upstream or 
downstream of try-5, other proteins on the sperm membrane that are important for receipt 
of the signal, or factors that interact with SNF-10 on the membrane.  Furthermore, 
additional spe-8-class mutants could be identified in such a screen.  Given what is known 
to activate sperm pharmacologically and that males depend on protease signaling, factors 
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that may be discovered include proteolysis regulators, secreted factors and membrane 
proteins.    
 
Results 
 To identify other genes involved in sperm activation, a swm-1 suppressor screen 
was performed by mutagenizing swm-1(me86) hermaphrodites with ethyl 
methanesulfonate (EMS).  Individual F1 hermaphrodites were placed on individual plates 
to lay progeny, and F2 male progeny were scored for suppression of premature sperm 
activation.  Strains homozygous for suppressor mutations were recovered from plates that 
showed at least 25% nonactivated males (Figure 4.1B).  The screen resulted in 30 
suppressor strains that suppressed premature sperm activation to varying degrees: 12 
strong, 16 medium and 2 weak suppressors (Figure 4.1C).  Complementation tests 
revealed that the strong suppressors were mainly mutations of try-5 and snf-10 but also 
included two new, unknown genes.  Medium suppressors represented at least 4 unknown 
genes and the two weak suppressors were not analyzed (Figure 4.1C).  Additionally, a 
spe-8-class mutant that showed hermaphrodite self sterility was identified.   
 
 
Characterizing phenotypes of swm-1 suppressor strains 
 The suppressor screen was performed over a period of 5 years and homozygous 
suppressor strains were stored at -80°C.  Therefore, I re-scored sperm activation of the 
strongest candidates, which included those that were not try-5 or snf-10, strong or 
medium suppressors, and those that did not complement each other (Figure 4.2A).  I 
found that some strains that were initially characterized as strong or medium suppressors 
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were weak suppressors upon re-scoring.  Therefore, I continued my analysis with the 
most consistently-strong suppressors, which included jn6, jn8, jn12, jn14 and jn19.  I 
tested whether the alleles were dominant or recessive and analyzed segregation frequency 
by analyzing F1 and F2 progeny (Figure 4.2B).  I found that jn6 and jn14 were semi-
dominant, as evidenced by non-activated F1 heterozygous males and more than 25% 
nonactivated F2 males.  The alleles jn8, jn12, and jn19 were recessive, as evidenced by 
non-activated F1 heterozygous males and no more than 25% non-activated F2 males 
(Figure 4.2B).  Lastly, I assessed whether suppressor strains were linked to swm-1, in 
which case I could look for variants near swm-1 (see materials and methods).  I found no 
evidence of linkage to swm-1 for any of the suppressors (Table 4.1) 
 
 
Mapping suppressor mutations 
 To map suppressor mutations, I used the single nucleotide polymorphism (SNP) 
mapping strategy developed by Davis et al. (2005).  This strategy takes advantage of 
SNPs that differ between the standard laboratory strain, N2, and the closely related 
Hawaiian strain, CB4856, which has 1 SNP/~1000bp.  SNPs can be detected using PCR 
and restriction digest detection assays, which facilitates mapping to a region of a 
chromosome by allowing recombination of the N2 and Hawaiian strain followed by 
pooling animals based on their mutant phenotype and genotyping SNPs (Figure 4.3) 
(Davis et al., 2005).  I used this strategy to map jn6 and jn19.  A previous member of the 
lab, Amanda Mulia, mapped jn15 to chromosome I between SNP markers 1,905,969 and 
12,047,594 (Figure 4.4A).  I mapped jn19 to chromosome II between SNP markers 
2,121,018 and 3,828,599 (Figure 4.4B) (Davis et al., 2005) .  jn6 appeared to be X-linked 
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(Figure 4.4C).  I also attempted to map jn8 but was unable to recover animals with the 
mutant, nonactivated phenotype.  jn14 samples were recovered and frozen. 
 The jn12 strain was mapped with a similar strategy using recombination of the 
suppressor strain with the Hawaiian strain.  However, rather than using PCR to detect 
SNPs, a larger sample of pooled DNA was collected for whole genome sequencing 
(WGS), followed by computational analysis of Hawaiian and N2 SNPs as described by 
Doitsidou et al.  (2010) and Minevich et al. (2012).  Following computational analysis 
using the Cloudmap software to detect SNPs, linkage of jn12 failed to show clear linkage 
to a single genomic locus (Figure 4.5) (Minevich et al., 2012).  Two regions of interest 
were notable: one on chromosome I and one on chromosome V (Figure 4.5A).  The 
reduction in Hawaiian alleles on chromosome I corresponds to a known N2/Hawaiian 
incompatibility that causes embryonic lethality (Seidel et al., 2011; Seidel et al., 2008).  
The Cloudmap pipeline was used to account for known N2/Hawaiian incompatibilities, 
divergence of strains from their published reference genome, picking errors, and 
sequencing errors, as described by Minevich et al. (2014).  After normalization, the 
chromosome I signal was largely absent (Figure 4.5B).  The reduction in Hawaiian alleles 
on chromosome V was expected since the swm-1(me86) mutation was introduced into the 
Hawaiian strain by recombination and backcrossing and is also seen in the SNP 
chromosome mapping strategy (4.5B).  It is interesting however that there were two 
predominant peaks, one between 8 - 8.5Mb and one between 9.5 -10Mb.  The genetic and 
genomic position of swm-1 likely corresponds to the smaller peak between 9.5 - 10Mb.  




Identification of candidate genes 
 Following whole genome sequencing, reads were aligned to the reference genome 
and variants were called using the online Galaxy platform as described by Minevich et al.  
(2012).  Variants were further filtered to include only protein coding and splice variants, 
homozygous mutations, lesions likely to be caused by EMS mutagenesis, inclusion of 
genes enriched in sperm and/or males, and mutations that were in common between 
mutants.  For jn15, the strongest candidate was the W09C3.2 gene, mainly because it was 
in the mapping region and predicted to be a membrane protein based on gene ontology 
(Table 4.2) (Ortiz et al., 2014; Reinke et al., 2000).  The strongest candidate gene for jn19 
was clec-130 (Table 4.3).  clec-130 is a c-type lectin predicted to have a carbohydrate 
binding function.  Furthermore, lectins are a class of genes commonly found in various 
seminal fluid proteomics studies (de Lamirande et al., 1997; Ram and Wolfner, 2009).   
 
 
Testing candidate genes for rescue of activation 
 To test the top candidate genes, I first attempted to rescue sterility of jn15 mutants 
and activation suppression of jn19 by introducing extrachromosomal arrays into the 
mutant strains.  Arrays included 3’ and 5’ surrounding regions of clec-130 (Figure 
4.6A,B) and W09C3.2 (Figure 4.6C,D).  No rescue was observed in either case (Figure 
4.6A-D).  Although introducing extrachromosomal arrays did not rescue the phenotypes, 
I could not fully rule out the candidates because arrays can have variable expression and 
are rapidly be silenced in the germline.  Furthermore, the jn19 strain was very 
challenging to inject arrays into because the gonad of the hermaphrodite was very small 
and twisted.   
  
82 
 As an alternative approach to thoroughly test the candidate activation genes, I 
introduced targeted deletions of candidate genes using CRISPR in the swm-1(me86) 
strain.  I obtained two alleles of W09C3.2 and one of clec-130 that resulted in deletion of 
most of the gene in both candidate genes (Figure 4.7 A,B and Figure 4.8A).  Neither 
deletion rescued the suppressor phenotypes (Figure 4.7 C and Figure 4.8B).  I then 
generated CRISPR reagents to create deletions of other candidate genes in the mapping 
region, this time not excluding genes based on whether they were enriched in the male 
and/or germline.  Isolation and testing of candidates beyond W09C3.2 and clec-130 was 
continued by another lab member, Abigail Greer.  Genes for which deletion reagents 
were made and a summary of results can be found in Table 4.4. 
 
Conclusions and future directions 
Identification of additional sperm activation factors requires further investigation.  
In the case of jn19, a previous lab member attempted mapping using the SNP 
chromosome strategy and was unsuccessful due to no clear signal.  Perhaps further 
analysis of jn19 should include backcrossing to a nonmutagenized N2 strain to eliminate 
unwanted mutations.  This process was initiated for jn19 after the failure to identify the 
gene, and future investigation of this strain should be carried out with the backcrossed 
version.  Furthermore, backcrossing should be considered for analysis of other suppressor 
strains, as many are sick and difficult to maintain.  For example, the jn19 strain had a 
very twisted gonad, which was seen in nearly every animal and made injecting constructs 
difficult.   
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In the case of jn15, the mapping region was very large, so identification of a gene 
may require additional mapping.  A useful strategy may be to use the finer SNP mapping 
described by Davis et al.  (2005).  The linkage signal identified on chromosome V of the 
jn12 strain is somewhat interesting due to its magnitude as compared to the signal closest 
to the genomic locus of swm-1 (Figure 4.5B).  Intriguingly, one variant near this region 
includes a male-enriched gene, B0507.7, that like SWM-1, is enriched in body wall 
muscle, coelomocytes and the germline (Ma et al., 2016; Spencer et al., 2011).   
In conclusion, this work can serve as a starting point for future investigation of 
candidate sperm activation genes.  One potential reason that I failed to identify additional 
genes may be functional redundancy of sperm activation genes.  Sperm activation is 
necessary for fertility and thus it is reasonable to suspect there are genes with redundant 
function to ensure fertility and perhaps the fact that many try-5 and snf-10 alleles were 
uncovered suggests that suppression may require more than one gene.   
 
 
Materials and methods 
Quantification of sperm activation 
Sperm activation of 48 hour post L4 adults was quantified as described in chapter 
2 materials and methods.  For strains carrying extrachromosomal arrays, animals were 
analyzed within 2 generations of array injection.   
 
Linkage to swm-1 
Candidate suppressor strains were crossed to the mIs11; him-1(e1490) strain and 
segregation frequencies for the activated and non-activated phenotypes were calculated to 
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determine whether the suppressor was closely linked to swm-1.  Segregation of the 
nonactivated phenotype at a 3/16 ratio was considered unlinked to swm-1.   
SNP chromosome mapping 
To determine the genomic location of the jn19 and jn15 mutations, single 
nucleotide polymorphism (SNP) chromosome mapping was performed as described by 
Davis et al. (2005).  To obtain samples for SNP mapping, swm-1(me86) him-5(e1490); 
jn19 L4 males were placed with L4 hermaphrodites of the Hawaiian swm-1(me86)him-
5(e1490) strain, a version of the CB4856 Hawaiian strain that had the closely-linked 
me86 and e1490 mutations introduced by recombination and backcrossing.  After four 
days, to allow for mating and growth of cross progeny, 20 L4 hermaphrodites were 
placed on individual plates and allowed to lay eggs for two days, after which they were 
collected and PCR was performed to identify heterozygotes using the SNP_YD1 SNP 
assay from the Davis et al.  (2005) primer set.  From 6 different heterozygous plates, 
between 18 and 24 L4 males were picked and incubated at 20ºC for 48 hours.  The sperm 
phenotype was scored by differential interference contrast microscopy as described in 
Chapter 2 and individual males were recovered and lysed in worm lysis buffer using 
standard protocols.  Lysates were then pooled based on their phenotype, activated or 
nonactivated, and used for SNP chromosome mapping 
SNP mapping by sequencing 
Recombinant F2 hermaphrodites segregating the suppressor phenotype were 
identified as described above and allowed to self-fertilize on 6cm plates until plates were 
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filled with adults.  The progeny of 50 F2 hermaphrodites were allowed to grow to the F3/ 
F4 generation, and starved for one day.  Animals were collected and pooled into a 15mL 
conicle tube by washing plates with M9, spun for 2-3 min, rinsed three times with M9 
and left for two hours at room temperature on a nutator to eliminate any remaining 
bacteria from the intestine.  Worms were rinsed three more times with M9, spun down, 
remaining M9 was removed, and samples were frozen at -80°C.  Genomic DNA was 
isolated using the Genomic DNA Extraction from Tissue kit (Thermo Fisher). 
Whole-genome sequencing 
DNA libraries were prepared for 150 bp paired-end sequencing by the University 
of Utah sequencing core and subjected to whole genome sequencing on an Illumina 
MiSeq sequencing platform. 
Transgenic strains 
To generate strains carrying extrachromosomal arrays, clec-130 and W09C3.2 
coding sequences that included 3’ and 5’ surrounding region were amplified from 
genomic DNA and injected into the mutant strains (Table 4.5). 
Candidate gene deletions 
To generate deletions in candidate genes, guide RNAs were designed using the 
benchling.com CRISPR design tool, which uses algorithms to identify and calculate 
gRNA efficiency and off-target scores as published by Hsu et al. (Table 4.6) (Hsu et al., 
2013).  gRNA sequences were cloned into the pDD162 plasmid as described in 
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Dickinson et al. (2013) and injected with the rol-6 (pRF4) and unc-22 (PCCM935) co-
CRISPR plasmids into N2 hermaphrodite gonads (Dickinson et al., 2013; Kim et al., 
2014).  Deletions were detected by PCR amplification of regions flanking the targeted 
site in F1 hermaphrodites. 
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Figure 4.1 Summary of suppressor screen.  A) Schematic of known sperm activation 
pathway genes including potential interacting factors that could be uncovered in a swm-1 
suppressor screen.  B) Summary of swm-1 suppressor screen.  C) Summary of alleles 
recovered from the swm-1 suppressor screen.   
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suppression # of alleles Genes
strong (>75%) 12 try-5 (5), snf-10 (5),
new (2)
medium (40-75%) 16 at least 4 unknown 














Figure 4.2 Strains isolated from swm-1 suppressor screen suppress premature 
activation of swm-1(me86) mutants.  A) Quantification of sperm activation of swm-1 
suppressors in 48 hr post L4 adult virgin males.  B) Quantification of segregation 
frequency of suppressor phenotypes.  Males contain either nonactivated (light grey), a 
mix of sperm and spermatids (grey), or activated sperm (black).  Phenotype of strains 
originally isolated with >40% of males containing nonactivated sperm.  Alleles jn10, 











































































Figure 4.3 Schematic of SNP mapping strategy.  Suppressor males are crossed to 
Hawaiian swm-1(me86) hermaphrodites.  Heterozygous hermaphrodites are identified by 
PCR and F1s are allowed to self-fertilize.  F2 males are scored for their activation 
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Figure 4.4 Chromosome mapping of jn15,  jn19, and jn6 suppressor strains.  Agarose 
gel images of jn15 and jn19 chromosome mapping results.  Arrows show regions of 
suppressor allele linkage to a chromosomal location where there is a decrease in 
Hawaiian SNPs.  Each pair represents SNP assay results from mutant recombinants (M) 
followed by a non-mutant (N) recombinants.  Blue dots indicate N2 bands, red dots 
indicate Hawaiian bands.  A) jn15 mapping.  jn15 is linked to chromosome I between 
SNP markers at 1,905,969 and 12,047,594.  B) jn19 is linked to chromosome II between 
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Figure 4.5 Cloudmap analysis of SNP mapping by sequencing jn12.  A) Graphs of 
SNP ratios across each chromosome.  Red line indicates LOSSES regression line (see 
Minevich et al.  2014).  Chromosome I shows a decrease in Hawaiian alleles at genomic 
position ~1.5Mb that corresponds to a known N2/Hawaiian incompatibility.  
Chromosome V shows a decrease in Hawaiian alleles between genomic positions 5-

























































































Figure 4.6 Extrachromosomal arrays of jn15 and jn19 candidate genes.  A) 
Schematic of clec-130 region amplified for testing array rescue of jn19 mutants.  B) 
Quantification of sperm activation phenotype of jn19 mutants carrying extrachromosomal 
arrays of the clec-130 gene and regulatory sequence.  Five independent array strains 
showed no rescue of the mutant phenotype.  Black indicates males that contain activated 
sperm, grey indicates males that contain a mix of sperm and spermatids, light grey 
indicates males that contain nonactivated sperm.  C) schematic of W09C3.2 region 
amplified for testing array rescue of jn15 mutants.  B) Quantification of hermaphrodite 
sterility phenotype of jn15 mutants carrying extrachromosomal arrays of the W09C3.2 
gene and regulatory sequence.  35 individual F1 hermaphrodites carrying arrays showed 





















































































































































































































































Figure 4.7 CRISPR deletion alleles of W09C3.2 A,B) Schematics of W09C3.2 deletion 
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Figure 4.8 CRISPR deletion of clec-130.  A) Schematic of the clec-130 deletion allele.  
B) Quantification of the sperm activation phenotype of the clec-130 deletion allele.  
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linked to swm-1?
jn6 10 – 16 – 74 no
jn8 16 – 3 – 81 no
jn12 16 – 15 – 58 no































Position Gene Reference Change Amino acid change Coverage 
predicted function/ 
conserved domain
1142104 Y48G8AL.10 C A G/C 21 nucleic acid binding, metal ion binding
2379644 sydn-1 C T M/I 29 neuron development
4124545 H31G24.1 G A G/R 33 embryo development
4711711 W09C3.2 G A S/N 31 splicing
4765803 M04F3.2 G T STOP 3 unknown
7070493 tofu-5 C T R/C 31 embryo development and reproduction
7301404 ttx-7 C G G/A 39 inositol biosynthesis
8817033 F36A2.9 C T P/L 29 Lipase, GDSL, SGNH hydrolase-type esterase domain
9246867 F36H2.2 G C R/G 35 membrane nucleoside transporter
9628158 hsr-9 C T S/F 24 BRCT- cell cycle regulation











































Position Gene Reference Change Amino acid change Coverage 
predicted function/
conserved domain
2757933 F29A7.8 C T G->R 23 unknown
2800568 nhr-119 G A S->L 19 DNA-binding, transcription factor
3573598 clec-130 G A G->S 31 carbohydrate-binding





Table 4.4 Additional candidate gene alleles tested 
 
 
suppressor candidate gene allele 
swm-1(me86) suppression 
(% of males with 
nonactivated sperm) 
jn19 clec-130 jn54 0% (n=31) 
jn19 clec-130 jn55 0% (n=23) 
jn19 clec130 jn56 no data 
jn19 clec-130 jn57 no data 
jn19 F29A7.8 Δ1 0% (n=52) 
jn19 nhr-119 jn53 0% (n=54) 
jn15 F36A2.9 none obtained no data 























































































































Table 4.6 List of guide RNAs used to target Cas9 to candidate suppressor genes 
gene guide RNA # target sequence (PAM) 
clec-130 3 5’-CAACGTCGCTGCAAAATATT(GGT) 
clec-130 4  5’-ATGCGGCACGCGTTCTTCGT(GGA) 
clec-130 5  5’-TCCCAATACAAGGAGAGTGAGGACAAT(GGA) 
clec-130 6 5’-TCCTTTAATCGGCCTTCTGGA(GGA) 
F29A7.8 1 5’-TAAAAATGTTAAAAATGTG(GGG) 
F29A7.8 2 5’-AAGCAGTCACTCATACAGTC(GGT) 
F29A7.8 4 5’-TTCTAGCTTCTACTGGCGGA(GGA) 
nhr-119 1 5’-TACAAGTGTCACTGCCGCCT(GGA) 
nhr-119 2 5’-GGTGAGGTATCCATACCGGA(GGT) 
nhr-119 3 5’-CACACAGCTACTAGCTAGGC(GGA) 
 W09C3.2 3 5’-CTGCAATTCTAATATCAAT(TGG) 
 W09C3.2 4 5’-CACAAGGATCGGAGTGATAT(GGA) 
 W09C3.2 5 5’-GAGTTTTCTTAGATGGAGAT(GGA) 
 W09C3.2 6 5’-AAAGGAGAAAGCTAAAAAG(AGG) 
F36A2.9 1 5’-GACCAGAAAATTCTACGCGG(GGA) 
F36A2.9 2 5’-TATGGAATAGGCTGATTGGC(GGA) 
tofu-5 1 5’-GAAAACTGACTCTGTCCAGT(GGT) 

















 In the work presented in this dissertation, I discovered that C. elegans males use a 
surprising cell type, muscle cells, to generate the extracellular environment within the 
gonad that ensures male fertility.  This work lead to extended studies on soma-germ line 
communication where I showed that other proteins behave this way and that this 
phenomenon has implications for future studies of C. elegans male fertility.  This work 
also led to the surprising discovery that SWM-1 is a seminal fluid protein and is present 
in the sperm migratory environment, though its role in the hermaphrodite remains 
unknown.  I tested models of how SWM-1 may be interacting with its likely target, TRY-
5, to demonstrate that they do not regulate localization of each other, a step towards 
understanding the molecular mechanism by which they act (Chapter 2).  I carried out 
investigation of the molecular protein domains of SWM-1, work that provided further 
evidence that SWM-1 may be a multifunctional protein (Chapter 3).  I went on to begin 
initial characterization of mutant strains that suppress the premature activation of swm-1 
mutants (Chapter 4).  Lastly, since I found that SWM-1 is present in the sperm migratory 
environment and found additional evidence that SWM-1 has multiple targets, I 
  
108 
investigated the possibility that it can affect sperm migration and competition between 
sperm of multiple males (Appendix).   
 
Extended discussions and future directions 
Soma-germ line interactions: considerations for C. elegans and beyond 
 The discovery that muscle is the critical source of the SWM-1 inhibitory signal is 
undoubtedly a curious and unexpected finding (Chapter 2).  It represents, to my 
knowledge, the first example of muscle being an important regulator of postmeiotic 
sperm maturation.  Why would regulating sperm motility rely on secretions from muscle?  
In the discussion in Chapter 2, I propose this tissue source can provide a persistent signal 
of inhibitor as opposed to somatic gonadal cells, which are less numerous and where 
secretion products are continually depleted during ejaculation.  In mammals, smooth 
muscle surrounds most tissues of the male reproductive tract, including the testis, 
epididymis and vas deferens.  It is known primarily for its structural role, providing 
peristaltic movement of sperm and seminal fluid and for androgen signaling that is 
important for epithelial function and identity (Belleannée et al., 2012; Welsh et al., 2010).  
No sperm maturation factors are known to be secreted from this muscle in any other 
organism.  Yet given the mounting evidence that muscle is an important endocrine organ, 
and that it is a key regulator in the stem cell niche in the drosophila intestine, 
contributions from muscle remain possible and may be important considerations for 
future studies (Iizuka et al., 2014; Lin et al., 2008; Pedersen, 2013; Pedersen and 
Febbraio, 2012; Pedersen, 2013). 
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 Future research in C. elegans may seek to determine the mechanism by which 
systemic factors in the pseudocoelomic cavity enter the seminal vesicle.  It is known that 
cells that compose the seminal vesicle express the gap junction proteins innexin 8 and 
innexin 9, and that these are important for germline proliferation and gametogenesis 
(Starich et al., 2001; Starich et al., 2014).  Presumably, these form channels much too 
small for a large protein such as mCherry or GFP to pass.  Indeed, I tested this idea and 
found that inx-9 inx-8 double mutant animals do not display premature sperm activation 
and that SWM-1::mCherry is present in the seminal vesicle of these mutants (data not 
shown).  These gap junction proteins are the only channels known to regulate soma-germ 
line interactions in C. elegans but my data suggest that there is another means by which 
factors are exchanged.  One way to study this may be by analysis of the movement of 
injected dyes or other molecules with known sizes and biochemical properties into the 
pseudocoelomic cavity.  This technique has been demonstrated in the hermaphrodite but 
may be adapted in males (Fares and Greenwald, 2001).   
 
C. elegans sperm activation  
One of the challenges to understanding the mechanisms of sperm activation lies in 
the fact that there are very likely unknown components of the pathway.  As I discuss in 
Chapter 4, this may be due to functional redundancy and may require multiple gene 
mutations to uncover a phenotype.  My finding that muscle is an important source of 
secreted factors that regulate sperm may aid in filtering variants identified in sequencing 
data, as such factors need not be limited to genes showing expression in the germline or 
gonad.  Perhaps additional filters using data from transcriptomic studies and 
  
110 
bioinformatic analysis of C. elegans genes can be applied to candidate gene lists.  These 
studies have identified putative secreted proteins in the C. elegans genome as well as a 
muscle transcriptome (Hutter and Suh, 2012; Ma et al., 2016).  Indeed, the fusion PCR 
method of generating guide RNAs to target Cas9 vastly facilitates rapid generation of 
deletion mutants to test candidates and should be used to generate deletions using 
CRISPR in future work (Ward, 2015).  Additionally, it may be interesting to analyze 
various known unc mutants, which display an uncoordinated phenotype.  Many such 
mutants have been described, and several affect body wall muscle.  Therefore, it may be 
interesting to analyze SWM-1 secretion and the sperm of these mutants (Gieseler et al., 
2017).   
 My investigation of the molecular mechanism by which SWM-1 and TRY-5 
interact included analysis of the co-localization of SWM-1 and TRY-5 in males and 
hermaphrodites and using spe-6 mutants to test whether localization of each protein was 
dependent on the other.  These results support a model where SWM-1 directly inhibits 
TRY-5 but further investigation including in vitro biochemical approaches will be 
required to determine the mechanism of action of SWM-1 and TRY-5.   
 
SWM-1 as a component of the sperm migratory environment 
 Although my investigation did not uncover a clear role for SWM-1 in the 
hermaphrodite uterus, localization of SWM-1 to the uterus suggests that it is important 
for some aspect of sperm success.  In my experiments, I tested whether vas deferens-
derived SWM-1 was important for sperm migration and/or male fertility.  Although I did 
not uncover a strong effect on male fertility, one caveat to my experiments may be the 
  
111 
inability to precisely modulate levels of SWM-1 using the tissue-specific promoters.  
Specifically, the body-wall promoter to generate “vas-” males does not account for the 
possibility that this promoter likely generates higher levels of SWM-1 in the seminal 
vesicle, which could compensate for SWM-1 absent from the vas deferens.   
SWM-1 is not required for hermaphrodite self-fertility yet it is expressed in the 
hermaphrodite, and, in a sensitized genetic background, its loss improves activation of 
self sperm (Stanfield and Villeneuve, 2006).  Furthermore, as mentioned in the discussion 
in Chapter 2, SWM-1 in the uterus may be important in less than ideal conditions or to 
provide a small benefit to reproductive success such as during sperm competition.  
Although I performed sperm competition experiments with swm-1 mutant males, control 
experiments did not support the experimental outcome and should be repeated.  
Additionally, these experiments may have suffered from a lack of sensitivity.  Therefore, 
a more sensitive assay may aid in identification of a phenotype.  In my experiments, 
sperm success was measured as total progeny sired by a male, a relatively crude measure 
of sperm success.  Perhaps a role may be uncovered by a simplified experiment such as 
beginning by testing male precedence over hermaphrodite sperm as a starting point and to 
provide a simplified experimental paradigm. Using total male fertility as a readout is 
further complicated by the significant variability between males in terms of mating 
frequency, and number of sperm and or seminal fluid transferred.  Therefore, perhaps a 
shorter window of mating time and verifying efficient mating may assist in identification 





C. elegans males as a model of male reproductive tract and secretory biology 
The cell biology of the male reproductive tract in C. elegans is poorly studied yet 
represents an opportunity to research secretory and male reproductive biology in a 
transparent tissue.  Through my investigation of the role of SWM-1 in sperm activation, I 
performed tissue-specific expression of SWM-1.  Notably, as mentioned in the discussion 
in Chapter 2, expression of secreted proteins in cells of the vas deferens, the valve and 
cuboidal cells, largely resulted in sequestration of proteins.  By contrast, neurons, 
epidermis, and muscle seem to secrete the same proteins, continually, without 
sequestration in vesicles like in the vas deferens.  Within vas deferens cuboidal cells, 
SWM-1 exhibits a distinct subcellular localization pattern.  In cuboidal cells, SWM-1 
(and TRY-5) are contained in numerous intracellular membrane-bound vesicles of 
various sizes.  The morphology and function of these cells is reminiscent of Drosophila 
accessory gland secondary cells which secrete exosomes, and seminal fluid (Corrigan et 
al., 2014; Sitnik et al., 2016).  The largest vesicles are closest to the apical membrane, 
presumably poised for rapid secretion during ejaculation, and the nucleus is located 
basally.  The size of the large vesicles is striking, some reaching up to 10µm in diameter 
and I often visualized what appeared to be smaller vesicles within these large vesicles.  
(data not shown).  A few electron micrographs of the vas deferens have been published 
(Lints and Hall, 2009).  These show some secretory globules near the apical membrane as 
I have observed.  However, these micrographs likely represent only one type of vas 
deferens cell, though at least three have been described.  Recent electron micrographs 
that have yet to be analyzed are likely to better characterize the nature of these vesicles 
(Kristin Fenker and Gillian Stanfield, University of Utah, personal communication). 
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One of the biggest challenges in understanding the role of seminal fluid and 
sperm maturation is that the tissues are difficult to obtain and must be fixed for analysis.  
C. elegans provides a unique opportunity to visualize seminal fluid production, secretion 
and function.  However, SWM-1 is only the third bona fide seminal fluid protein in C. 
elegans shown to be transferred to the hermaphrodite uterus during mating.  Although 
there is not a complete list of known seminal fluid proteins for C. elegans, several have 
been shown to be expressed in the vas deferens, have a secretion signal and represent the 
classes of proteins commonly found in the seminal fluid of most species (Thoemke et al., 
2005).  Furthermore, with the extensive transcriptomic analysis that has been reported on 
secreted and male-enriched transcripts and proteins in C. elegans, a candidate list of 
factors is feasible to generate (Ortiz et al., 2014; Reinke et al., 2000; Reinke et al., 2004).   
 Future studies on seminal fluid production, secretion and secretory vesicle 
dynamics should take advantage of abundant markers that are available for these 
structures.  I have generated strains that have the intracellular vesicles of valve cells and 
cuboidal cells marked with a GFP membrane marker as well as secreted mCherry-marked 
seminal fluid in both valve and cuboidal cells (data not shown).  Interestingly, in my 
initial analysis of these strains, it seems that there is likely a distinct cell type of valve 
cells that does not express either of these markers.  This further highlights the utility of 
this system which is simplified but resembles the tubular structures of the male 
reproductive system of other organisms where there are multiple cell types that together 
orchestrate the requirements of sperm success.   
 Overall, the work presented here has uncovered novel cell biology and opened 
many other avenues of research that can be pursued using the C. elegans male.  My hope 
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is for future studies to investigate the role of SWM-1 in the sperm migratory path, SWM-
1 TIL domain function, identification of other sperm activation genes and studies to 
identify other seminal fluid proteins and lastly, investigation of the fascinating membrane 
biology of the C. elegans vas deferens.  
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APPENDIX 
ANALYSIS OF SPERM MIGRATIO AND COMPETITION IN SWM-1 MUTANTS 
Introduction 
Since I showed that SWM-1 is a seminal fluid protein contributed to the uterus 
during mating and that hermaphrodites also produce SWM-1 that is present in the uterus, 
I hypothesized that it can affect some aspect of postmating sperm success.  I decided to 
test if SWM-1 could affect sperm migration and competition because it does not affect 
hermaphrodite self-fertility and SWM-1 in male seminal fluid is not critical for male 
fertility.  This lead me to hypothesize that it has a different role in the uterus aside from 
its known role as an inhibitor of activation (Stanfield and Villeneuve, 2006) (Chapter 2).  
Interestingly, overexpression of SWM-1 in seminal fluid reduces male fertility, an effect 
that can be relieved by removing SWM-1 in hermaphrodites (Chapter 2).  This suggests 
that the levels of SWM-1 in the uterus are optimized for sperm success.  However, these 
experiments show that SWM-1 can affect sperm and do not address whether these affects 
are due to SWM-1s normal role in sperm success or if there is toxicity by the 
overexpression.  Thus, its presence and role in the uterus remains mysterious.  Despite 
the fact that it is not critical for fertility, it is nevertheless supplied by both males and 
hermaphrodites to the uterus, implicating that it has an important function, perhaps to 
optimize some aspect of gamete success.  Intriguingly, the drosophila seminal fluid 
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protein Acp62F is also a TIL domain serine protease inhibitor present in the female 
spermatheca that affects ovulation and sperm competition (Mueller et al., 2008). 
Results 
First, I analyzed male sperm migration in uteri that lacked SWM-1.  To do this, I 
bypassed the premature sperm activation defect of swm-1 mutants by using snf-10 
mutants.  SNF-10 is an SLC-6 transporter on the surface of the sperm cell membrane that 
was identified in a swm-1 suppressor screen (Fenker et al., 2014).  snf-10 is downstream 
of swm-1 and mutations in snf-10 suppress the premature sperm activation of swm-1 
mutants.  Importantly, while snf-10 mutants cannot respond to TRY-5 in males, they are 
efficiently transferred to hermaphrodites and can activate via the hermaphrodite sperm 
activation pathway with no effect on male fertility (Fenker et al., 2014).  Therefore, I 
analyzed sperm migration of swm-1 snf-10 double mutants in the uteri of swm-1 mutant 
hermaphrodites using males dyed with mitotracker, which labels mitochondria, allowing 
me to visualize sperm migration.  I also included the temperature sensitive fem-1(hc17ts) 
mutation which renders hermaphrodites self-sterile because they do not produce self 
sperm when reared at the restrictive temperature (Doniach and Hodgkin, 1984).  This 
allowed me to target to the analysis of the effect of male-derived SWM-1 on male 
fertility.  I found that as compared to snf-10 control sperm, snf-10 swm-1 mutant sperm 
migration is normal (Figure A.1).   
To test swm-1 for a role in sperm competition, I set up matings with animals that 
lacked SWM-1 in the uterus and assessed sperm success by counting total progeny.  To 
create this uterine environment that lacked SWM-1, I used swm-1 snf-10 double mutant 
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males, which bypasses the sperm activation phenotype of swm-1 mutants because snf-10 
mutant males cannot prematurely activate in response to TRY-5 in the male but they can 
be trans activated via the hermaphrodite pathway.  Importantly, swm-1 snf-10 mutant 
sperm display wild-type levels of fertility but whether SWM-1 in the uterus is important 
for sperm competition or some other aspect of sperm success is unknown (Fenker et al., 
2014).  To specifically test the role of SWM-1 on male sperm success, I mated males to 
swm-1 fog-2 mutant hermaphrodites.  The fog-2 mutation is a temperature-sensitive 
mutation that renders hermaphrodites self-sterile when reared at 25ºC because they do not 
produce sperm self sperm (Schedl and Kimble, 1988).  This allowed me to test the role of 
male-derived SWM-1 on male sperm success.   
I used a sequential mating paradigm to compete the sperm of two males and used 
the GFP transgene, mIs11 in one of the males to determine paternity of the most 
successful sperm, which was determined by total progeny.  In control sequential matings 
with two wild-type males, there was no bias in paternity, as has previously been shown.  
By contrast, in matings where SWM-1 was provided by the second male but not the first 
male, first male sperm showed precedence.  Furthermore, when SWM-1 was completely 
absent in the uterus, the second male showed strong paternal bias (Figure A.2A).  This 
result was robust, as three independent repeats of this experiment showed the same result.  
However, in control matings where I reversed the order of the male that contained the 
GFP transgene, the result was not recapitulated (Figure A.2B).   
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Discussion 
These results may indicate that SWM-1 could be important for the retention of 
position in the spermatheca.  In matings where SWM-1 was absent from the uterus, 
sperm from the second male outcompeted sperm from the first male.  Yet, when SWM-1 
was provided by the second male but not the first, first male sperm took precedence, 
perhaps because seminal fluid spreads into the site of fertilization faster than sperm can 
migrate to it, allowing first male sperm to utilize the SWM-1 to retain their position.  This 
phenomenon of factors being important for retention of position is known as defensive 
sperm competitive ability.  However, these results cannot be confirmed without 
recapitulating the effect in the control experiment where the male that contains the mIs11.  
This control experiment however was only repeated once and perhaps warrants further 
testing.  Going forward, further SWM-1 competition experiments may benefit from a 
more sensitive assay.  Since SWM-1 derived from somatic body wall muscle is required 
for fertility but seminal fluid SWM-1 is not, perhaps its role as a seminal fluid is subtle 
and only provides a slight benefit to the reproductive process.    
Materials and methods 
Sperm competition assay 
24 hour post L4 adult males were placed with 24 hour post L4 adult 
hermaphrodites and allowed to mate for 3 hours in a 1:1 ratio followed by removal of the 
first male and addition of the second male, which was also allowed to mate for 3 hours 
and then removed from the plate.  Hermaphrodites were then transferred to fresh plates 
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and transferred every 16 hours.  The mIs11 GFP transgene was included in the second 
male to determine paternity of offspring and total progeny were counted. 
Sperm migration 
Sperm migration was visualized and quantified by labeling males with the 
mitochondrial dye Mitotracker Red CMXRos (Life Technologies) as described in 
Stanfield and Villeneuve (2006).  Mitotracker labeled males were allowed to mate with 
hermaphrodites for 30 minutes and then removed and mated hermaphrodites were 
analyzed to determine the position of sperm in the uterus.  
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Figure A.1 swm-1 mutant sperm migration.  Heat map showing the position of 
mitrotracker labeled sperm in the uterus in 30 minute intervals over a period of 3 hours.  
Position of sperm in each hermaphrodite is shown for wild-type (top rows, blue shading), 
snf-10 (middle rows, green shading), and snf-10 swm-1 (bottom rows, pink shading) 
mutant male sperm.  Numbers indicate the percent of sperm at each position in the uterus.  
Shade of red coloring correlates with percent of sperm at each position.  Positions in the 
uterus are represented in egg-lengths from vulva.  Abbreviations indicate egg-length, EL 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
 
Figure A.2 Sperm competition in SWM-1 mutant males.  A) Total progeny sired by the 
second male from sequential matings between wild type and swm-1 mutant males.  “second 
males” harbored the mIs11 transgene.  B) Control experiment with first males harboring 
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